Mobileye (MBBYF) Inactive F-1/A16 Mar 15Registration statement (foreign) (amended)Financial data

Company Profile

Document_And_Entity_Informatio

Document And Entity Information	12 Months Ended
Document And Entity Information	Dec. 31, 2014
Document And Entity Information [Abstract]
Entity Registrant Name	Mobileye N.V.
Entity Central Index Key	1607310
Trading Symbol	mbly
Document Type	F-1/A
Amendment Flag	FALSE
Document Period End Date	31-Dec-14

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
CURRENT ASSETS
Cash and cash equivalents	$339,881	$72,560
Restricted and short-term bank deposits	2,315	5,084
Marketable securities	32,895	46,718
Trade accounts receivables, net	15,806	12,490
Inventories	17,626	11,354
Other current assets	9,820	7,025
TOTAL CURRENT ASSETS	418,343	155,231
LONG-TERM ASSETS
Property and equipment, net	8,787	5,697
Funds in respect of employee rights upon retirement	7,969	6,962
Other assets	1,307	338
TOTAL LONG-TERM ASSETS	18,063	12,997
TOTAL ASSETS	436,406	168,228
CURRENT LIABILITIES
Accounts payable and accrued expenses	17,870	11,096
Employee related accrued expenses	3,961	3,338
Other current liabilities	5,739	1,441
TOTAL CURRENT LIABILITIES	27,570	15,875
LONG TERM LIABILITIES
Liability in respect of employee rights upon retirement	9,350	8,313
Long term liabilities	4,812	1,402
TOTAL LONG TERM LIABILITIES	14,162	9,715
COMMITMENTS AND CONTINGENT LIABILITIES (Note 7)
TOTAL LIABILITIES	41,732	25,590
SHAREHOLDERS' EQUITY
Ordinary shares	2,511
Additional paid-in capital	523,315	240,563
Accumulated other comprehensive income (loss)	-181	612
Accumulated deficit	-130,971	-100,887
TOTAL SHAREHOLDERS' EQUITY	394,674	142,638
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	436,406	168,228
Class B Ordinary shares
SHAREHOLDERS' EQUITY
Ordinary shares		75
Class C Ordinary shares
SHAREHOLDERS' EQUITY
Ordinary shares		35
Class D Ordinary shares
SHAREHOLDERS' EQUITY
Ordinary shares		415
Class E Ordinary shares
SHAREHOLDERS' EQUITY
Ordinary shares		155
Class F1 Ordinary shares
SHAREHOLDERS' EQUITY
Ordinary shares		165
Class F2 Ordinary shares
SHAREHOLDERS' EQUITY
Ordinary shares		480
Class A Ordinary shares
SHAREHOLDERS' EQUITY
Ordinary shares		345
Ordinary shares (with liquidation preferences)
SHAREHOLDERS' EQUITY
Ordinary shares		$680

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parentheticals) (EUR €)	Dec. 31, 2014	Dec. 31, 2013	Aug. 15, 2013	Jun. 28, 2013
Ordinary shares, par or stated value per share (in dollars per share)	€ 0.01
Ordinary stock, shares authorized	1,012,565,725
Ordinary stock, shares, issued	214,554,061
Ordinary stock, shares, outstanding	214,554,061
Class B Ordinary shares
Ordinary shares, par or stated value per share (in dollars per share)		€ 0.01
Ordinary stock, shares authorized		25,000,000	25,000,000
Ordinary stock, shares, issued		6,703,520
Ordinary stock, shares, outstanding		6,703,520
Class C Ordinary shares
Ordinary shares, par or stated value per share (in dollars per share)		€ 0.01
Ordinary stock, shares authorized		25,000,000	25,000,000
Ordinary stock, shares, issued		3,390,490
Ordinary stock, shares, outstanding		3,390,490
Class D Ordinary shares
Ordinary shares, par or stated value per share (in dollars per share)		€ 0.01
Ordinary stock, shares authorized		50,000,000	50,000,000
Ordinary stock, shares, issued		32,164,955
Ordinary stock, shares, outstanding		32,164,955
Class E Ordinary shares
Ordinary shares, par or stated value per share (in dollars per share)		€ 0.01
Ordinary stock, shares authorized		20,000,000	20,000,000
Ordinary stock, shares, issued		11,749,700
Ordinary stock, shares, outstanding		11,749,700
Class F1 Ordinary shares
Ordinary shares, par or stated value per share (in dollars per share)		€ 0.01		€ 0.01
Ordinary stock, shares authorized		15,000,000	15,000,000
Ordinary stock, shares, issued		14,326,650
Ordinary stock, shares, outstanding		14,326,650
Class F2 Ordinary shares
Ordinary shares, par or stated value per share (in dollars per share)		€ 0.01
Ordinary stock, shares authorized		65,000,000	65,000,000
Ordinary stock, shares, issued		41,547,280
Ordinary stock, shares, outstanding		41,547,280
Class A Ordinary shares
Ordinary shares, par or stated value per share (in dollars per share)		€ 0.01
Ordinary stock, shares authorized		100,000,000	100,000,000
Ordinary stock, shares, issued		32,070,835
Ordinary stock, shares, outstanding		32,070,835
Ordinary shares (with liquidation preferences)
Ordinary shares, par or stated value per share (in dollars per share)		€ 0.01
Ordinary stock, shares authorized		200,000,000
Ordinary stock, shares, issued		60,559,715
Ordinary stock, shares, outstanding		60,559,715

CONSOLIDATED_STATEMENTS_OF_OPE

CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income Statement [Abstract]
REVENUES	$143,637	$81,245	$40,285
COST OF REVENUES	37,040	21,130	12,219
GROSS PROFIT	106,597	60,115	28,066
OPERATING COSTS AND EXPENSES:
RESEARCH AND DEVELOPMENT, net	36,930	22,309	15,866
SALES AND MARKETING	12,912	12,331	6,434
GENERAL AND ADMINISTRATIVE	71,437	10,277	7,418
OPERATING PROFIT (LOSS)	-14,682	15,198	-1,652
INTEREST INCOME	1,305	1,059	1,531
FINANCIAL INCOME (EXPENSES), net	-4,442	1,389	402
PROFIT (LOSS) BEFORE TAXES ON INCOME	-17,819	17,646	281
BENEFIT (TAXES) ON INCOME	-12,265	2,274	-334
NET INCOME (LOSS)	-30,084	19,920	-53
BASIC AND DILUTED LOSS PER SHARE:
Amount allocated to participating shareholders		-16,105
Adjustment as a result of benefit to participating shareholders		-229,832
Net loss applicable to Ordinary shares for 2014 and applicable to Class A Ordinary Share for 2013 and 2012	-30,084	-226,017	-53
Basic and diluted (in dollars per share)	($0.28)	($6.03)
WEIGHTED AVERAGE NUMBER OF SHARES USED IN COMPUTATION OF LOSS PER ORDINARY SHARE FOR 2014 AND PER CLASS A ORDINARY SHARE FOR 2013 AND 2012 (IN THOUSANDS)
Basic and diluted (in shares)	107,942	37,477	40,191
PRO FORMA BASIC AND DILUTED LOSS PER ORDINARY SHARE (UNAUDITED)
Net loss	($30,084)
Basic and Diluted (unaudited pro forma) (in dollars per share)	($0.15)
WEIGHTED AVERAGE NUMBER OF SHARES USED IN COMPUTATION OF PRO FORMA LOSS PER SHARE (IN THOUSANDS)
Basic and Diluted (unaudited pro forma) (in shares)	207,214

CONSOLIDATED_STATEMENTS_OF_COM

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Statement of Comprehensive Income [Abstract]
NET INCOME (LOSS)	($30,084)	$19,920	($53)
OTHER COMPREHENSIVE INCOME (LOSS)
Change in net unrealized gains (losses) on marketable securities	-63	100	130
Less: reclassification adjustment for net losses (gains) included in net income	-730	291	419
TOTAL OTHER COMPREHENSIVE INCOME (LOSS)	-793	391	549
TOTAL COMPREHENSIVE INCOME (LOSS)	($30,877)	$20,311	$496

STATEMENTS_OF_CHANGES_IN_SHARE

STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (USD $)	Total Shares	Additional paid in capital	Accumulated other comprehensive income (loss)	Accumulated deficit	Total
In Thousands, except Share data	Total Shares	Additional paid in capital	Accumulated other comprehensive income (loss)	Accumulated deficit	Total
Balance at Dec. 31, 2011	$2,205	$187,822	($328)	($120,754)	$68,945
Balance (in shares) at Dec. 31, 2011	191,874,340
Exercise of options	5	267			272
Exercise of options (in shares)	111,540
Comprehensive income (loss)			549	-53	496
Share-based compensation		1,855			1,855
Balance at Dec. 31, 2012	2,210	189,944	221	-120,807	71,568
Balance (in shares) at Dec. 31, 2012	191,985,880
Issuance of shares, net of issuance costs	55	27,827			27,882
Issuance of shares, net of issuance costs (in shares)	4,297,995
Exercise of options	85	9,661			9,746
Exercise of options (in shares)	6,229,270
Comprehensive income (loss)			391	19,920	20,311
Share-based compensation		13,131			13,131
Balance at Dec. 31, 2013	2,350	240,563	612	-100,887	142,638
Balance (in shares) at Dec. 31, 2013	202,513,145
Issuance of Ordinary shares in connection with initial public offering, net of issuance costs of $12.2 million	112	195,797			195,909
Issuance of Ordinary shares in connection with initial public offering, net of issuance costs of $12.2 million (in shares)	8,325,000
Exercise of options	49	10,102			10,151
Exercise of options (in shares)	3,715,916
Comprehensive income (loss)			-793	-30,084	-30,877
Share-based compensation		76,853			76,853
Balance at Dec. 31, 2014	$2,511	$523,315	($181)	($130,971)	$394,674
Balance (in shares) at Dec. 31, 2014	214,554,061

STATEMENTS_OF_CHANGES_IN_SHARE1

STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parentheticals) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014
Statement of Stockholders' Equity [Abstract]
Ordinary shares issuance cost	$12.20

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss) for the year	($30,084)	$19,920	($53)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation	2,551	1,694	1,245
Exchange rate differences on cash and cash equivalents	3,087	-280	-103
Liability in respect of employee rights upon retirement	1,037	2,177	1,390
Loss (gain) from funds in respect of employee rights upon retirement	510	-337	-176
Loss (gain) from marketable securities	1,139	-767	226
Loss on disposal of property and equipment		22	12
Share-based compensation	76,853	13,131	1,855
Changes in asset and liabilities:
Trade accounts receivables, net	-3,316	-5,389	-1,758
Other current assets	-2,795	-4,103	185
Inventories	-6,272	-2,079	-4,955
Other long-term assets	-969	-57	-129
Account payables and accrued expenses	6,056	3,593	869
Employee-related accrued expenses	623	775	514
Other current-liabilities	4,298	-532	-796
Long-term liabilities	3,410	420	9
Net cash provided by (used in) operating activities	56,128	28,188	-1,665
CASH FLOWS FROM INVESTMENT ACTIVITIES
Investment in short-term deposits and restricted cash	-33,146	-21,758	-25,957
Proceeds from short-term deposits and restricted cash	35,915	26,974	30,894
Proceeds from maturities / sales of marketable securities	31,252	14,342	35,402
Purchase of marketable securities	-19,361	-24,166	-37,187
Funds in respect of employee right upon retirement	-1,517	-1,736	-1,013
Purchase of property and equipment	-5,378	-2,592	-1,526
Net cash provided by (used in) investing activities	7,765	-8,936	613
CASH FLOWS FROM FINANCING ACTIVITIES
Issuance of shares, net of issuance costs	196,364	28,303
Exercise of options	10,151	9,746	272
Net cash provided by financing activities	206,515	38,049	272
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	270,408	57,301	-780
BALANCE OF CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR	72,560	14,979	15,656
EXCHANGE RATE DIFFERENCES ON CASH AND CASH EQUIVALENTS	-3,087	280	103
BALANCE OF CASH AND CASH EQUIVALENTS AT END OF YEAR	339,881	72,560	14,979
SUPPLEMENTARY INFORMATION ON ACTIVITIES NOT INVOLVING CASH FLOWS
Non cash purchase of property and equipment	573	310	121
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Income taxes paid	$2,609	$405	$613

GENERAL

GENERAL	12 Months Ended
GENERAL	Dec. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GENERAL	NOTE 1 GENERAL
	Organization
	Mobileye N.V. was incorporated in the Netherlands in 2001 and is the parent company of the following wholly owned subsidiaries: Mobileye, Inc., a company incorporated in the United States (the “US subsidiary”), Mobileye Technologies Ltd., a company incorporated in Cyprus (the “Cypriot subsidiary”), Mobileye Vision Technologies Ltd., a company incorporated in Israel (the “Israeli subsidiary”), Mobileye Japan Ltd, a company incorporated in Japan (the “Japanese subsidiary”), Mobileye Germany GmbH, a company incorporated in Germany (the “German subsidiary”), and Mobileye Auto Service (Shanghai) Co. Ltd. (the “Chinese subsidiary”).
	The Company and its subsidiaries together (the “Company”) is a global leader in the design and development of camera-based Advanced Driver Assistance Systems (“ADAS”) covering the entire range of vision applications for onboard driving assistance.
	The Company’s Chief Operating Decision Maker manages the Company on the basis of two reportable segments: (i) Original Equipment Manufacturing (“OEM”) and (ii) After Market (“AM”). The OEM segment supplies core intelligence of complete systems to Tier 1 manufacturers in the automotive industry. In the OEM segment the Company supplies System on Chip (SoC) which includes core intelligence to be ultimately implemented within new vehicles through Tier 1 manufacturers who are system integrators to the automotive industry. In the AM segment the Company sells a complete system which offers a variety of advanced driver assistance functions to customers being primarily fleet commercial vehicles, fleet management system providers, new vehicle dealers and importers either directly, through distributors and insurance companies. See also note 2j and 12b for the Company’s major customers.
	Initial public offering
	On August 6, 2014, the Company completed its initial public offering (IPO), which included an issuance of 8,325,000 Ordinary shares (with no liquidation preference), at $25 per share, before underwriting discounts and commissions.
	The IPO generated proceeds to the Company of $197.7 million net of underwriting discounts and commissions, before $1.8 million of expenses related to the IPO. In connection with the IPO, the Company also generated proceeds of $1.5 million from the exercise of 1,463,051 stock options.

SIGNIFICANT_ACCOUNTING_POLICIE

SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
SIGNIFICANT ACCOUNTING POLICIES
	NOTE 2 SIGNIFICANT ACCOUNTING POLICIES
	The consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”).
	a. Use of estimates
	The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclose contingent liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the years reported. Actual results could differ from those estimates. On an on-going basis, management evaluates its estimates, judgments and assumptions. The most significant estimates and assumptions relate to write down of inventory, employee compensation in connection with equity awards, realizability of deferred tax assets, provision for uncertain tax positions and contingencies.
	b. Functional currency
	The currency of the primary economic environment in which the operations of the Company and its subsidiaries are conducted is the United States dollar (the “Dollar”).
	Virtually most product revenues of the Company and its subsidiaries are derived in Dollars. Most purchases of materials and components are made in Dollars. Thus, the functional currency of each of the Company and its subsidiaries is the Dollar.
	Monetary accounts maintained in currencies other than the Dollar are re-measured using the official exchange rate at the balance sheet date. Operational accounts and non-monetary balance sheet accounts are measured and recorded at the rate in effect at the date of the transaction or average rates. The effects of foreign currency re-measurements are recorded in the consolidated statements of operations as “financial income (expenses)”.
	c. Principles of consolidation
	The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. Intercompany balances and transactions, including profits from intercompany sales not yet realized outside the Company, have been eliminated upon consolidation.
	d. Cash and cash equivalents
	All highly liquid investments, which include short-term bank deposits, that are not restricted as to withdrawal or use and the period to maturity of which does not exceed three months at the time of investment, are considered to be cash equivalents.
	e. Short-term and restricted bank deposits
	Short-term and restricted bank deposits are deposits with maturities of more than three months but less than one year. The short-term and restricted bank deposits include approximately $2.2 million and $2.5 million as of December 31, 2014 and December 31, 2013, respectively, as collateral for bank guarantees. In addition, a total of $77 thousand and $78 thousand are restricted as collateral for the Company’s credit cards as of December 31, 2014 and December 31, 2013, respectively.
	f. Marketable securities
	The Company classifies its investments in marketable securities as available-for-sale. Accordingly, these securities are measured at fair value with unrealized gains and losses reported in accumulated other comprehensive income (loss) (“OCI”). Realized gains and losses on sales of investments, and a decline in value that is considered as other than temporary, are included in the consolidated statements of operations as “financial income (expenses), net”. Interest and amortization and accretion of premiums and discounts on debt securities are recorded as interest income.
	The Company classifies marketable securities as available-for-sale as either current or non-current based on maturities and management’s reasonable expectation with regard to those securities.
	An other-than-temporary impairment has occurred if the Company does not expect to recover the amortized cost basis of the debt security. If the Company does not intend to sell the impaired debt security, and it is not more likely than not it will be required to sell the debt security before the recovery of its amortized cost basis, the amount of the other-than-temporary impairment recognized is limited to the portion attributed to the credit loss. The remaining portion of the other-than-temporary impairment related to other factors is recognized in other comprehensive income (loss).
	h. Risk factors
	Concentration of credit risk
	Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash equivalents, short-term deposits and marketable securities.
	The Company’s cash equivalents, short-term deposits and marketable securities are mainly invested with major Israeli, Swiss and U.S. banks. Management believes that the financial institutions holding the Company’s investments are financially sound, and accordingly, minimal credit risk exists with respect to these investments. See also notes 2j and 12b for the Company’s major customers.
	Dependence on a single supplier
	The Company purchases all its chips from a single supplier. Any problems that occur and persist in connection with the manufacture, delivery, quality or cost of the assembly and testing of inventory could have a material adverse effect on the Company’s business and financial condition. The agreement expires on December 31, 2022.
	i. Fair value measurement
	The Company measures fair value and discloses fair value measurements for financial and non-financial assets and liabilities. Fair value is based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The accounting standard establishes a fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described below:
	Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.
	Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data or active market data for similar but not identical assets or liabilities.
	Level 3: Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.
	In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible and considers credit risk in its assessment of fair value.
	j. Trade accounts receivable, net
	The Company’s accounts receivable balances are due from companies primarily in the car manufacture industry. Credit is given based on an evaluation of a customer’s financial condition and generally, collateral is not required. Trade accounts receivable from sales of products are typically due from customers within 30 – 90 days. Trade accounts receivable balances are stated at amounts due from customers net of an allowance for doubtful accounts. Accounts outstanding longer than their original contractual payment terms, are considered past due. The Company determines its allowance by considering a number of factors, including the length of time accounts receivable are past due, the Company’s previous loss history from such customers, customer’s current ability to pay its obligation to the Company. Payments subsequently received on such receivables are credited to the allowance for doubtful accounts. The allowance for doubtful accounts is determined with respect to specific debts that are doubtful of collection. The Company writes-off accounts receivable when they become uncollectible.
	k. Inventories
	Inventories are stated at the lower of cost or market value. Cost is computed using standard cost, which approximates average cost. The Company analyzes and adjusts excess and obsolete inventories primarily based on future demand forecasts. Although the Company makes every effort to ensure the accuracy of its forecasts of future product demand, any significant unanticipated changes in demand or technological developments would significantly impact the value of the inventory and the reported operating results. If actual market conditions are less favorable than the Company’s assumptions, additional write-downs may be required.
	Inventories are written-down for estimated excess and obsolescence, based on assumptions about future demand and market conditions. Once written-down, a new lower cost basis for that inventory is established.
	l. Property and equipment
	Property and equipment are recorded at cost and depreciated over their estimated useful lives using the straight-line method.
	Annual rates of depreciation are as follows:
		%
	Computers and electronic equipment (mainly 33%)		15 – 33
	Vehicles		15
	Office furniture and equipment		7
	Equipment		33
	Leasehold improvements are amortized by the straight-line method over the shorter of the term of the lease and estimated useful life of the improvements.
	m. Impairment of long-lived assets
	Long-lived assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. In the event that the sum of the expected future cash flows (undiscounted and without interest charges) of the long-lived assets is less than the carrying amount of such assets, an impairment charge would be recognized, and the assets would be written down to their estimated fair values.
	n. Research and development, net
	Research and development expenses are expensed as incurred, and consist primarily of personnel, facilities, equipment and supplies for research and development activities.
	Participations in research and development expenses for research and development projects are recognized on the basis of the costs incurred and are deducted from research and development expenses in the statement of operations. The Company does not receive any additional compensation or royalties upon completion of the project. The participation reimbursement received by the Company is not dependent on having future benefit from the project. All intellectual property generated from these arrangements are exclusively owned by the Company.
	Reimbursement payments for research and development projects are recognized on the basis of the costs incurred and are deducted from (netted against) research and development expenses in the statement of operations. Research and development reimbursements of $9,884 thousand, $10,511 thousand and $9,994 thousand were offset against research and development costs in the years ended in December 31, 2014, 2013 and 2012, respectively.

	o. Comprehensive income (loss)
	Comprehensive income (loss) consists of net income (loss) and other gains and losses affecting equity that under US GAAP are excluded from the net income (loss). For the Company, such items consist of unrealized gains and losses on available-for-sale securities. Realized gains and losses on available-for-sale securities are included in the consolidated statements of operations as “financial income (expenses) net”.
	p. Revenue recognition
	The Company’s revenue results from sales of its products sold through its two operating segments, Original Equipment Manufacturing (“OEM”) and After Market (“AM”).
	The Company recognizes revenue related to sales of its products, net of volume discounts, provided that (i) persuasive evidence of an arrangement exists, (ii) delivery has occurred, (iii) the price is fixed or determinable and (iv) collectibility is reasonably assured. Delivery is considered to have occurred when the product is shipped to the customer and title and risk of loss have transferred to the customer. The Company evaluates the creditworthiness of its customers to determine that appropriate credit limits are established prior to the acceptance of an order.
	Revenue of sales of products to resellers and distributors occurs upon delivery of products to the resellers and distributors. The Company does not give distributors any adjustments to cover price adjustments. The Company does not provide rights of return to its customers.
	q. Shipping and handling
	Shipping and handling costs on sales are classified as a component of cost of revenues. The Company generally does not charge its customers for such expenses.
	r. Share-based compensation
	Equity awards granted to employees and directors are accounted for using the grant date fair value. The fair value of share-based payment transactions is determined based on the Black-Scholes option pricing model and recognized as an expense over the requisite service period, net of estimated forfeitures. The Company estimates forfeitures based on historical experience and anticipated future conditions.
	The Company elected to recognize compensation cost for awards that have a graded vesting schedule using the accelerated multiple-option approach.
	Equity awards granted to non-employees are re-measured at each reporting period at fair value until they have vested. The fair value of equity awards is charged to the statement of operations over the service period.
s. Taxes on income
Deferred taxes are determined utilizing the assets and liabilities method, which is based on the estimated future tax effects of the differences between the financial accounting and tax bases of assets and liabilities under the applicable tax laws. Deferred tax balances are computed using the tax rates expected to be in effect when those differences reverse. A valuation allowance in respect of deferred tax assets is provided if, based upon the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized.
The Company did not provide for deferred taxes attributable to dividend distribution out of retained tax-exempt earnings from “Benefitted Enterprise” and “Preferred Company” plans since such earnings are intended to be permanently reinvested or can be recovered in a tax-free manner. Management considers such retained earnings to be essentially permanent in duration. The Company may incur additional tax liabilities in the event of intercompany dividend distributions by its subsidiaries. Such additional tax liabilities in respect of foreign subsidiaries has not been provided for in the Financial Statements, as it is the Company’s intention to permanently reinvest the foreign subsidiaries’ earnings. With respect to domestic subsidiaries, the Company records a deferred tax liability unless the reported amount of the investment can be recovered tax-free without significant cost, and the Company expects to ultimately use that means of recovery.
Results for tax purposes for the Israeli subsidiary are measured and reflected in NIS (see also Note 9). The Company has not provided deferred income taxes on the differences resulting from changes in exchange rate and indexation.
The Company follows a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon ultimate resolution. The Company’s policy is to include interest and penalties related to unrecognized tax benefits within income tax expense. Such liabilities are classified as long-term, unless the liability is expected to be settled in cash within twelve months from the balance sheet date.
t. Provision for warranty
The Company provides warranties for its products, which vary with respect to each contract and in accordance with the nature of each specific product, for terms of one to three years.
The Company estimates the costs that may be incurred under its warranty and records a liability in the amount of such costs at the time the product is shipped. The Company periodically assesses the adequacy of its recorded warranty liabilities and adjusts the amounts as necessary.
Provision for warranty as of December 31, 2014 and 2013, was $470 thousand and $307 thousand, respectively.
u. Contingencies
Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. Company’s management assesses such contingent liabilities, which inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company that may result in such proceedings, Company’s management evaluates the perceived merits of any legal proceedings as well as the perceived merits of the amount of relief sought or expected to be sought.
Management applies the guidance in ASC 450-20-25 when assessing losses resulting from contingencies. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability is recorded in the Company’s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would be disclosed. Legal fees are expensed as incurred.
v. Basic and diluted net profit (loss) per share
Basic earnings (losses) per share are presented in conformity with the two-class method required for participating securities for the periods prior to their conversion upon the Company’s IPO in August 2014, when all classes of shares were converted to Ordinary shares.

Under the two-class method, the earnings per share for each class of shares are calculated assuming 100% of the Company’s earnings are distributed as dividends to each class of shares based on their contractual rights. In addition, since all classes other than Class A Ordinary shares, did not participate in losses, for the years ended December 31, 2014 and 2012 these shares are not included in the computation of basic loss per share.
Basic earnings (losses) per share are computed by dividing net income or loss applicable to ordinary shareholders by the weighted average number of Class A ordinary shares outstanding for each period prior to the Company’s IPO and by the weighted-average number of ordinary shares for the periods commencing the Company’s IPO.
Diluted earnings (losses) per share are calculated by dividing net income or loss applicable to ordinary shareholders by the fully-diluted weighted-average number of Class A ordinary shares outstanding during each period prior to the Company’s IPO and by the weighted-average number of ordinary shares for the periods commencing the Company’s IPO.
For the years ended December 31, 2014 and 2013, all outstanding options and all Ordinary shares (with liquidation preference) and Class B, C, D, E, F1 and F2 shares were excluded from the calculation of the diluted earnings per share, since their effect was anti-dilutive. For the year ended December 31, 2012, all outstanding options and all Ordinary shares (with liquidation preference) and Class B, C, D and E shares were excluded from the calculation of the diluted earnings per share, since their effect was anti-dilutive.
During the year ended December 31, 2013, as a result of the investment transaction described in note 8g, the Company redeemed 43,456,175 aggregate shares of classes B, C, D, E and Ordinary shares (with liquidation preference), which were subsequently converted to Class F1 and Class F2 shares and sold to new investors. In connection with this redemption, the Company transferred value to the preferred shareholders, which was calculated as the difference between (1) the fair value of consideration transferred and (2) the carrying value of the 43,456,175 shares of classes B, C, D, E and Ordinary shares (with liquidation preferences) surrendered. The difference, in the amount of $230 million, was recorded as a reduction to net income applicable to Class A Ordinary shares used to calculate basic and diluted loss per share.
Pro forma basic net loss per share for the year ended December 31, 2014, as presented on the face of the statement of operations, was computed to give effect to the conversion of all convertible preferred shares using the as-if converted method into ordinary shares as if the conversion had occurred as of the beginning of the period presented.
w. Impact of recently issued accounting pronouncements
On May 28, 2014, the FASB and IASB issued their converged standard on revenue recognition. The objective of the revenue standard (ASC 606) is to provide a single, comprehensive revenue recognition model for all contracts with customers to improve comparability within industries, across industries, and across capital markets. The revenue standard contains principles that an entity will apply to determine the measurement of revenue and timing of when it is recognized. The underlying principle is that an entity will recognize revenue to depict the transfer of goods or services to customers at an amount that the entity expects to be entitled to in exchange for those goods or services. For public companies, the revenue standard is effective for the first interim period within annual reporting periods beginning after December 15, 2016 (as of January 1, 2017 for the Company) and early adoption is not permitted. The Company is currently evaluating the impact the standard will have on its financial statements.
In August 2014, the Financial Accounting Standards Board (“FASB”) issued amended guidance related to disclosure of uncertainties about an entity’s ability to continue as a going concern. The new guidance requires management to evaluate whether there is substantial doubt about the entity’s ability to continue as a going concern and, as necessary, to provide related footnote disclosures. The guidance has an effective date of December 31, 2016. The Company believes that the adoption of this new standard will not have a material impact on its consolidated financial statements.
x. Adoption of new Accounting Standard
In July 2013, the FASB issued ASU No. 2013-11 Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists (ASU No. 2013-11). ASU No. 2013-11 amends the guidance within Accounting Standards Codification (ASC) Topic 740, “Income Taxes”, to require entities to present an unrecognized tax benefit, or a portion of an unrecognized tax benefit, in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward. The Company adopted ASU No. 2013-11 on January 1, 2014. There were no material presentation changes resulting from the adoption of ASU No. 2013-11.

SUPPLEMENTARY_CONSOLIDATED_BAL

SUPPLEMENTARY CONSOLIDATED BALANCE SHEETS INFORMATION	12 Months Ended
SUPPLEMENTARY CONSOLIDATED BALANCE SHEETS INFORMATION	Dec. 31, 2014
Supplementary Statement Of Balance Sheet Information [Abstract]
SUPPLEMENTARY CONSOLIDATED BALANCE SHEETS INFORMATION	NOTE 3 SUPPLEMENTARY CONSOLIDATED BALANCE SHEETS INFORMATION
		December 31,
		2014		2013
		U.S. dollars in thousands
	a. Other current assets
	Government institutions		1,026		856
	Prepaid expenses		1,948		1,260
	Deferred taxes		605		3,025
	Other account receivables		5,277		1,263
	Other		964		621
			9,820		7,025
	b. Property and equipment, net
	Computers and electronic equipment		13,848		9,323
	Vehicles		617		656
	Office furniture and equipment		665		541
	Leasehold improvements		3,839		2,928
	Equipment		476		356
			19,445		13,804
	Less – accumulated depreciation and amortization		10,658		8,107
			8,787		5,697


	Depreciation expense totaled $2,551 thousand, $1,694 thousand and $1,245 thousand in the years ended December 31, 2014, 2013, and 2012, respectively.

		December 31,
		2014		2013
		U.S. dollars in thousands
	c. Account payable and accrued expenses
	Account payable		12,016		7,550
	Accrued expenses		5,854		3,546
			17,870		11,096
	d. Other current Liabilities
	Institutions		2,215		90
	Deferred income		1,303		1,052
	Advances from customers		1,180		299
	Other		1,041		—
			5,739		1,441

FAIR_VALUE_MEASUREMENT

FAIR VALUE MEASUREMENT

12 Months Ended

Dec. 31, 2014

Fair Value Disclosures [Abstract]

FAIR VALUE MEASUREMENT

NOTE 4 FAIR VALUE MEASUREMENT

The Company measures fair value and discloses fair value measurements for financial assets and liabilities. Fair value is based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

The fair value of marketable securities is based on quoted market prices in active markets (level 1). Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment.

As of December 31, 2014, the Company held government and corporate debt securities with an aggregated cost of $33,228 thousand and an aggregated fair value of $32,895 thousand. The gross unrealized gains and losses as of December 31, 2014 were $68 thousand and $249 thousand, respectively. The aggregate fair value of investments with unrealized losses as of December 31, 2014 was $19,529 thousand.

During the year ended December 31, 2014, the Company recognized other-than-temporary impairment of $152 thousand related to debt securities.

As of December 31, 2013, the Company held debt securities and equity securities. The cost, aggregate fair value and unrealized holding gains and losses by major security types were as follows:

As of December 31, 2013

Cost

Aggregate

Unrealized

fair value

gains, net

U.S. dollars in thousands

Government and corporate debentures

45,518

46,114

596

Other (equity securities)

588

604

46,106

46,718

612

During the years ended December 31, 2013 and 2012 no other-than-temporary impairments were recognized by the Company.

Contractual maturities of investments in available-for-sale debt securities were as follows:

Fair Value as of

December 31,

2014

Due in 1 year

7,732

Due in 2 years

8,011

Due in 3 years

5,726

Due in 4 years

6,112

Due in 5 years

3,773

Due after 5 years

1,541

32,895

Short-term deposits included in cash and cash equivalents were $192,456 thousand and $31,935 thousand, as of December 31, 2014 and 2013, respectively.

The carrying amount of financial instruments, which include cash and cash equivalents, accounts receivable and accounts payable, approximate fair value because of their generally short maturities.

INVENTORIES

INVENTORIES	12 Months Ended
INVENTORIES	Dec. 31, 2014
Inventory Disclosure [Abstract]
INVENTORIES	NOTE 5 INVENTORIES
	Inventories are composed of the following:
		December 31,
		2014		2013
		U.S. dollars in thousands
	Raw materials		2,070		2,387
	Work in process		9		282
	Finished goods and spare parts		15,547		8,685
	Total		17,626		11,354

	Inventory of $156 thousand, $23 thousand and $231 thousand was written down, as a component of cost of revenues, in the years ended December 31, 2014, 2013 and 2012, respectively.

EMPLOYEE_BENEFITS

EMPLOYEE BENEFITS	12 Months Ended
EMPLOYEE BENEFITS	Dec. 31, 2014
Compensation and Retirement Disclosure [Abstract]
EMPLOYEE BENEFITS	NOTE 6 EMPLOYEE BENEFITS
	Israeli labor laws and agreements require severance payments upon dismissal of an employee or upon termination of employment in certain other circumstances. The Company’s liability in respect of employee rights upon retirement required by Israeli law is covered by deposits with financial institutions and by accrual.
	The Israeli subsidiary’s liability in respect of Israeli employees’ rights upon retirement is calculated pursuant to Israeli Severance Pay Law based on the most recent salary of the employees multiplied by the number of years of employment as of the balance sheet date. The liability is presented on the undiscounted basis as a long-term liability. The Israeli subsidiary records an expense for the net increase in its severance liability. The Israeli subsidiary’s liability for all of its Israeli employees is covered for by monthly deposits with severance pay funds.

	The deposited funds include profits accumulated up to the balance sheet date. The deposited funds may be withdrawn only upon the fulfillment of the obligations pursuant to Israeli Severance Pay Law or labor agreements. The value of the deposited funds is based on the cash surrender value of these policies and includes profits (or loss) accumulated through the balance sheet date. The amounts funded are presented separately as funds in respect of employee rights upon retirement.

	Severance pay expenses for the Israeli subsidiary were $1,990 thousand, $1,433 thousand and $1,321 thousand for the years ended December 31, 2014, 2013 and 2012, respectively.
	The US subsidiary has a defined contribution retirement plan (the “Contribution Plan”) under the provisions of Section 401(k) of the Internal Revenue Code (“Code”) that covers eligible U.S. employees as defined in the Contribution Plan. Participants may elect to contribute up to a maximum amount prescribed by the Code. The US subsidiary, at its discretion, makes matching contributions equal to the mandatory minimum 3% non elective (employer level) safe harbor contribution of the participant’s annual compensation. For the years ended December 31, 2014, 2013 and 2012 the US subsidiary made 401(k) Plan contributions of approximately $56 thousand, $87 thousand, and $57 thousand, respectively.

COMMITMENTS_AND_CONTINGENT_LIA

COMMITMENTS AND CONTINGENT LIABILITIES	12 Months Ended
COMMITMENTS AND CONTINGENT LIABILITIES	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENT LIABILITIES	NOTE 7 COMMITMENTS AND CONTINGENT LIABILITIES
	Commitments
	a. Lease agreements
	In September 2013, the Israeli subsidiary exercised its option to extend the existing operating lease agreement for a period of additional 5 years until the end of February 2019. In July 2014, the Israeli subsidiary came to an agreement with the lessor with regards to the lease terms, which included an amendment to the lease payments rate, as well as the lease of additional space. The Israeli subsidiary was also granted an option to extend the lease term for an additional five year period, at then-current market rates.
	As part of this agreement the Israeli subsidiary had secured a bank guarantee in the amount of approximately $1,283 thousand (denominated in NIS).
	Rent expenses for the Company for the years ended December 31, 2014, 2013 and 2012 were $2,211 thousand, $1,447 thousand and $1,060 thousand, respectively.
	The Israeli subsidiary subleases to a related party, which is an entity co-founded by the Chairman of the Board and CTO and the President and CEO of the Company (“the Company’s founders”) 850 square meters (approximately 9,000 square feet) from the Israeli subsidiary for monthly rent of $29 per square meter. The lease expires on August 1, 2015 with automatic one year renewals. The Company believes the sublease terms are comparable to those that would have been reached in an arm’s-length negotiation.
	Future minimum annual lease commitments under all of the Company’s operating lease agreements are as follows:
		U.S. dollars
		in thousands
	Years ending December 31:
	2015		2,141
	2016		2,097
	2017		2,082
	2018		2,082
	2019		347
			8,749

	Other lease agreements
	The Israeli subsidiary leases vehicles under vehicle operating lease agreements. Vehicles lease expenses for the Company for the years ended December 31, 2014, 2013 and 2012 were $661 thousand, $600 thousand, and $554 thousand, respectively.
	Future minimum annual lease commitments under operating lease agreements are as follows:
		U.S. dollars
		in thousands
	Years ending December 31:
	2015		425
	2016		317
	2017		171
			913

	b. Royalty and commissions bearing agreements
	The Company signed a number of license agreements and technology transfer agreements with third parties. The agreements allow the Company to utilize and leverage the third parties’ technology in order to integrate it into the Company’s products (“Integrated Product”). In consideration thereof, the Company is obligated to pay royalties to each of the third parties, for each unit of the applicable Integrated Product sold to other parties. As a result, the Company recorded during the years ended December 31, 2014, 2013 and 2012, expenses of approximately $1,768 thousand, $920 thousand and $554 thousand in the financial statements, respectively. These expenses are classified as a component of cost of revenues.
	In connection with multiple contractor and agent agreements, the Company is committed to pay commissions ranging between 1% and 3% of the direct sales earned directly as a result of these agreements. These expenses are classified as a component of sales and marketing.
	c. Bank guarantees
	As of December 31, 2014, the Israeli subsidiary had secured several bank guarantees in a total amount of approximately $1,599 thousand (denominated in NIS) mainly in connection with a lease agreement and the employment encouragement plan of the Israeli Ministry of Industry, Trade and Labor plan it had undertaken.
	d. Contingent liabilities:
	In October 2012, the Cypriot and Israeli subsidiaries received a lawsuit filed by a former consultant of the Cypriot subsidiary, claiming Euro 260 thousand (approximately $340 thousand) for early termination of the consultancy agreement, reputational damages and interest. On January 22, 2014, the Court rejected the former consultant’s claim and the case was dismissed.

EQUITY

EQUITY	12 Months Ended
EQUITY	Dec. 31, 2014
Stockholders' Equity Note [Abstract]
EQUITY	NOTE 8 EQUITY
	Share capital
	a.
	As of December 31, 2014, the issued share capital of the Company is composed of Ordinary shares at EUR 0.01 par value. As of December 31, 2013, the issued share capital of the Company was composed of Class A Ordinary shares (with no liquidation preference), Ordinary shares (with liquidation preference), Class B, C, D, E, F1 and F2 shares, all at EUR 0.01 par value.
	b.
	On August 6, 2014, the Company completed its IPO. For additional information see note 1.


	c.
	In July 2014, the Company’s shareholders approved a five-for-one stock split of all classes of the Company’s shares, which was effective July 10, 2014. The stock split had the following effects: (i) each outstanding share of any class was increased to five shares of the same class; (ii) each outstanding warrant or option to purchase Ordinary shares was proportionately increased on a five-for-one basis; and (iii) the exercise price of each outstanding warrant or option to purchase Ordinary shares was proportionately decreased on a one-for-five basis. All of the share and per share amounts have been adjusted, on a retroactive basis, to reflect this stock split.


	As part of the stock split, the shareholders approved an increase to the number of authorized shares of all classes of shares to 500,000,000 shares authorized of which 200,000,000 are authorized ordinary shares, 100,000,000 are authorized class A shares, 25,000,000 are authorized class B shares, 25,000,000 are authorized class C shares, 50,000,000 are authorized class D shares, 20,000,000 are authorized class E shares, 15,000,000 are authorized class F1 shares and 65,000,000 are authorized class F2 shares. The accompanying financial statements and notes to the financial statements give retroactive effect to these increases for all periods presented.

	In addition, in July 2014, the Company’s Articles were amended to convert all classes of shares into one class of Ordinary shares on a 1:1 basis and the Company’s shareholders approved the increase to the number of authorized shares into 1,012,565,725 Ordinary shares, each at EUR 0.01 par value.

	d.
	On August 15, 2013 the Company amended its Articles of Association. Accordingly, the authorized shares were divided differently among the different classes of shares (while the total authorized share capital remained the same). Following this amendment, authorized shares are as follows: 100,000,000 class A shares, 200,000,000 Ordinary shares, 25,000,000 class B shares, 25,000,000 class C shares, 50,000,000 class D shares, 20,000,000 class E shares and 80,000,000 class F shares divided into (i) 15,000,000 F1 shares and (ii) 65,000,000 F2 shares.

	e.
	Prior to the IPO, in August 2014, the Company had different classes of shares, all of which converted to Ordinary shares on a one-to-one basis in connection with the IPO. Significant terms were as follows:

	Voting
	The holders of Ordinary Shares (with liquidation preference), and Class A, B, C, D, E, F1 and F2 Ordinary shares had identical voting rights. The holders of class D shares had a veto right with respect to certain related party transactions and the right to designate a director of the Company. The holders of F1 shares had the right effectively to designate a director of the Company. The holders of Class D shares and Class F shares had the right to veto further issuances of Class D shares and Class F shares, respectively. All of the special rights described above were terminated upon the closing of the IPO on August 6, 2014.
	Conversion
	Each holder of Class B, C, D, E, F1 and F2 shares had the right, at any time and from time to time, to convert each share held by the holder into one fully paid and non-assessable Ordinary share (with liquidation preference). The Class A shareholders had the right to convert to Ordinary shares (with liquidation preference), however, their shares did not have any additional rights nor liquidation preference as a result of such conversion. Immediately prior to the IPO, all shares of the Company were automatically converted into Ordinary shares, with no effective liquidation rights.
	Anti-Dilution Rights
	Certain Ordinary shares (with liquidation preference), and certain Class B, C, D, E, F1 and F2 shares had certain contractual anti-dilution rights.
	At any time prior to an initial public offering of the Company’s securities, in the event the Company issued any shares to a third party in return for an investment (the “Subsequent Investment”) and the Subsequent Investment is made based on a price per share of less than the “Adjusted Price Per Share” (as defined in the relevant Investment Agreement to which a shareholder is a party), then the Investors (as defined in the relevant agreement) shall be issued additional shares of the Company of the relevant class of shares held by such shareholder, for no further consideration, such that the number of shares of the relevant class held by such Investor shall be increased to such number of shares as such Investor would have held had it originally purchased such shares for the lower price at which shares are proposed to be issued.
	The Company determined that the anti-dilution feature is a contingent beneficial conversion feature at the date of issuance. Since this was contingent upon a future event that never occurred, it has not been recorded in the consolidated financial statements as of December 31, 2014.
	Liquidation Preference
	In the event of any liquidation, dissolution or winding up of the Company, the Company undertook that (i) each holder of Class B and Ordinary shares (with liquidation preference) that is a party to an investment agreement providing for a liquidation preference and (ii) each holder of Class C, D, E, F1 and F2 shares shall be entitled to receive, out of the assets of the Company invested by such holder in the Company (the “Consideration Amount of such holder). Such distribution will be made pro rata to all holders entitled to a liquidation preference, until each holder has received the full Consideration Amount to which it is entitled, after which such holder will not participate in the preferential distribution. After the full preferential amount referred to above has been distributed to all shareholders entitled thereto, the Company’s remaining assets and funds available for distribution will be distributed pro rata to all shareholders. There was no deemed liquidation that requires redemption of the shares.
	Following is a summary of the equity activity for the years ended December 31, 2014, 2013 and 2012:
				Ordinary				Class A				Class B				Class C				Class D		Class E		Class F1		Class F2		Ordinary
				shares				Ordinary				Ordinary				Ordinary				Ordinary		Ordinary		Ordinary		Ordinary		shares (with
								shares				shares				shares				shares		shares		shares		shares		liquidation
																												preference)
				Number of shares – issued and outstanding
	Balance, as of December 1, 2012									40,190,595				11,913,135				4,818,795			43,469,535		14,047,435		—		—		77,434,845
	Exercise of options									—				—				—			—		—		—		—		111,540
	Balance, as of December 31, 2012									40,190,595				11,913,135				4,818,795			43,469,535		14,047,435		—		—		77,546,385
	Exercise of options									—				—				—			—		—		—		—		6,229,270
	Issuance of F1 shares									—				—				—			—		—		4,297,995		—		—
	Investment transaction (see note 8(g))									-8,119,760				-5,209,615				-1,428,305			-11,304,580		-2,297,735		10,028,655		41,547,280		-23,215,940
	Balance, as of December 31, 2013									32,070,835				6,703,520				3,390,490			32,164,955		11,749,700		14,326,650		41,547,280		60,559,715
	Exercise of options – prior to IPO					—				—				—				—			—		—		—		—		1,463,051
	Conversion upon IPO closing					203,976,196				-32,070,835				-6,703,520				-3,390,490			-32,164,955		-11,749,700		(14,326,650		(41,547,280		-62,022,766
	IPO					8,325,000				—				—				—			—		—		—		—		—
	Exercise of options – commencing					2,252,865				—				—				—			—		—		—		—		—
	IPO					2,252,865				—				—				—			—		—		—		—		—
	Balance, as of December 31, 2014					214,554,061				—				—				—			—		—		—		—		—

	g. Investment transactions
	On June 28, 2013, the Company entered into a share purchase agreement with an investor pursuant to which the Company agreed to sell and issue to the investor 4,297,995 Class F1 Shares par value EUR 0.01 each, at a purchase price of $6.98 per share and total consideration of $30,000,000. On the same day, investors, including the investor in the preceding sentence, entered into an agreement with the Company and a newly formed Dutch private company, Driving Momentum BV (“Newco”), which owned 500 Ordinary shares (with liquidation preference) of the Company pursuant to which Newco agreed to sell to the investors an aggregate of 10,028,655 Class F1 and 41,547,280 Class F2 shares. NewCo then purchased 51,575,935 issued and outstanding Class A, Ordinary Shares (with liquidation preference), Class B, Class C, Class D and Class E shares of the Company from existing shareholders, at a purchase price of US $6.61 (net of expenses) per share. Newco converted the 51,575,935 shares it had acquired from the existing shareholders into 10,028,655 Class F1 and 41,547,280 Class F2 shares. The closing of the purchase of the 4,297,995 F1 shares from the Company and the 10,028,655 Class F1 and 41,547,280 Class F2 shares from Newco occurred on August 22, 2013. The repurchase conversion and sale of the shares took place simultaneously. Subsequent to the completion of these transactions, Newco, which did not have any substantive net assets, was merged with the Company. This transaction was accounted for as benefit to participating shareholders of the Class A, B, C, D, E and Ordinary shares (with liquidation preference).
	h. Employee and Non-employee stock options
	Options to employees and service providers
	The Company has adopted a stock option plan (the “2003 Plan”), whereby up to 11% (out of the Company’s issued and outstanding aggregate number of shares of all classes) options may be granted to employees and service providers for purchase of the Company’s Ordinary shares. In May 2014, the Company increased the pool of options to be available under the 2003 Plan to up to 18% of the issued and outstanding shares of the Company.
	Under the terms of the 2003 Plan, the board of directors or the designated committee will grant options and will determine the period over which options become exercisable and the exercise terms. The Company usually grants options that vests over a period of 4.5 years and expires 7 years after grant. Each option can be exercised into one Ordinary share EUR 0.01 par value of the Company.
	In December 2014, the board of directors approved and the Company adopted its 2014 Equity Incentive Plan (the “2014 Plan”). Under the 2014 Plan, the board of directors or the designated committee will grant stock options, restricted shares and restricted share units (“RSUs”). The total number of shares available under both the 2003 Plan and the 2014 Plan shall not exceed 38,619,123. Generally, the 2014 Plan provides for options that vests over a period of 4.5 years and expires 7 years after grant and for RSUs that vests over a period of 3 years. Each option can be exercised into one Ordinary share EUR 0.01 par value of the Company.
	No additional awards will be granted under the 2003 Plan.
	Both of the Plans with respect to Israeli employees are intended to be governed by the terms stipulated by Section 102 of the Israeli Income Tax Ordinance. In accordance with the capital gain track chosen by the Company and pursuant to the terms thereof, the Company is not allowed to claim, as an expense for tax purposes, the amounts credited to employees as a benefit, including amounts recorded as salary benefits in the Company’s accounts, in respect of options granted to employees under the Plans — with the exception of the work-income benefit component, if any, determined on the grant date. Options granted to employees from other countries are subject to similar terms with certain changes required for local regulations.
	The following table summarizes information regarding outstanding and exercisable options under the Company’s plans as of December 31, 2014:
		Exercise price			Outstanding								Exercisable
		(US $)			Number				Weighted average				Number				Weighted average
remaining									remaining
contractual life									contractual life
(in years)									(in years)
				0.096 – 0.376			2,064,619				2.2				1,959,619				2.05
				0.554 – 0.776			558,620				2				558,620				2
				1.13 – 2.991			2,270,460				1.96				2,270,460				1.96
	3.7					7,480,320				4.6				6,305,750				4.68
	6.98 – 7.1					13,783,600				6.07				4,087,525				6.03
	25 – 36.83					625,100				6.58				—				—
						26,782,719				4.94				15,181,974				4.2

The following table summarizes the option activity for the year ended December 31, 2014 for options granted to employees, directors and service providers:
			Number				Weighted				Aggregated
							average				intrinsic value(1)
							exercise price
							$				U.S. dollars
							$				in thousands
Options outstanding at beginning of year					17,494,470				2.97
Changes during the year:
Granted(2)					13,455,700				7.82
Exercised					-3,715,916				2.73
Forfeited					-451,535				3.43
Options outstanding at end of year					26,782,719				5.44				940,693
Options exercisable at year-end					15,181,974				3.79				558,181


-1
The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the closing stock price of $40.56 of the Company’s ordinary share on December 31, 2014. This represents the potential pre-tax amount receivable by the option holders had all option holders exercised their options as of such date.

-2
On January 13, 2014 the Company granted the Company’s founders, who are also shareholders, 11,500,000 options, exercisable into the same amount of the Company’s Ordinary shares, at an exercise price of $6.98 per share; 3,850,000 options were vested immediately and the remainder vest over two years.

On September 7, 2014 the Company granted four of its directors 200,000 options, exercisable into the same amount of the Company’s ordinary shares, at an exercise price of $25.0 per share, which are subject to graded vesting. Those options were granted in the money.

Subsequent to December 31, 2014, the Company granted to its employee additional 75,650 options exercisable into the same amount of the Company’s Ordinary shares, at an average exercise price of $36.49 per share, and 233,505 RSUs.


At December 31, 2014, there were 190,000 options outstanding with a weighted average exercise price of $4.17 and weighted average remaining contractual life of 2.95 years, which were granted to service providers. At December 31, 2014, 100,000 of these options were exercisable.
The fair value of options granted was estimated using the Black-Scholes option pricing model, and based on the following assumptions:
			Year ended December 31,
			2014			2013	2012
Risk-free interest rate			0.7% – 2.17%			0.19% – 2.74%	0.88% – 1.33%
Expected option term			3.82 – 7.27 years			1 – 12.35 years	6.26 – 7.06 years
Expected price volatility			36% – 55%			42% – 53%	52% – 53%
Dividend yield			0%			0%	0%
Weighted average fair value at the date of grant			$7.28			$2.22	$2.05
The interest rate for periods within the contractual life of the award is based on the U.S. Treasury yield curve in effect at the time of grant.
The Company’s computation of expected volatility was based on comparable companies.
The expected option term for options awards that were at the money when granted (plain vanilla options) was calculated in accordance with the simplified method in accordance with ASC 718, as adequate historical experience is not available to provide a reasonable estimate. The simplified method will continue to apply until enough historical experience is available to provide a reasonable estimate of the expected term. The expected term of options granted to non-employee service providers is based on the contractual life.
The Company has historically not paid dividends and has no foreseeable plans to pay dividends.
As of December 31, 2014, approximately $36.9 million of total unrecognized compensation expense related to unvested share-based compensation grants under the Plan. That cost is expected to be recognized over a weighted-average period of 2.02 years.
Share-based compensation expenses included in the Company’s Statements of Operations were:
			Year ended December 31,
			2014				2013				2012
			U.S. dollars in thousands
Cost of revenues					27				16				32
Research and development, net					6,130				2,320				1,124
Sales and marketing					5,201				5,861				565
General and administrative					65,495				4,934				134
Total stock-based compensation					76,853				13,131				1,855


During December 2013, the Company’s Board of Directors approved the modification of certain outstanding stock options previously granted to employees and service providers. The modification was for the extension of all outstanding options with a termination date earlier than December 31, 2014. The options will now expire on December 31, 2016. The modification resulted in compensation expense of $823 thousand that was recorded during the year ended December 31, 2013 and included in the above table.


In connection with the closing of the IPO and in accordance with their original terms, the vesting period for certain options was accelerated such that options to purchase 4,950,000 Ordinary shares vested and became exercisable upon the closing of the IPO. Of the 4,950,000 options, options to purchase 3,375,000 Ordinary shares were granted to the Company’s founders who are also shareholders. The acceleration resulted in compensation expense of $6.6 million that was recorded during the year ended December 31, 2014 and included in the above table.

TAXES_ON_INCOME

TAXES ON INCOME	12 Months Ended
TAXES ON INCOME	Dec. 31, 2014
Income Tax Disclosure [Abstract]
TAXES ON INCOME	NOTE 9 TAXES ON INCOME
	a. Tax rates
	Each of the Company’s subsidiaries is taxed under the applicable law, in accordance with the country of its residence. The enacted statutory tax rates applicable to the significant subsidiaries of the Company’s subsidiaries are as follows:
	Cypriot subsidiary — prior to the Company’s reorganization of its internal corporate structure, which took place in July 2014, income is taxed at the corporate tax rate. The Corporate tax rate in Cyprus was 12.5% in 2014. Interest income is taxed at the Defence tax rate. The Defence tax rate in Cyprus was 30% (effective from May 1, 2013). After the Company’s reorganization, the Cypriot subsidiary is taxed under the Israeli law.
	The Israeli subsidiary is taxed under the Israeli law. Income not eligible for benefits under the Investment Law mentioned below is taxed at the corporate tax rate. Corporate tax rates in Israel were as follows: 2012 — 25%, 2013 — 25%, 2014 — 26.5%.
	The amount of tax-exempt profits earned by the Company from Benefited Enterprises through December 31, 2014 is approximately $7 million. Deferred taxes have not been provided for such tax-exempt income, as those earnings can be recovered tax-free and the Company expects to ultimately use that means of recovery.

	Deferred taxes in respect of foreign subsidiaries have not been provided for as it is the Company’s intention to permanently reinvest the foreign subsidiaries’ earnings. An assessment of the tax that would have been payable had the Company’s foreign subsidiaries distributed their income to the Company is not practicable because of the multiple tax rates and different tax regimes through the years.
	Israel Tax benefits under the Law for Encouragement of Capital Investments, 1959 (the “Law”)
	Benefited Enterprise
	Commencing 2005, the Israeli subsidiary has been granted with a “Benefited Enterprise” status, which provides certain benefits for a period of ten years, including tax exemptions for undistributed income and reduced tax rates.
	The proportion of the Israeli subsidiary’s taxable income entitled to tax exemption is calculated on the basis of the ratio between the turnover attributed to the “Benefited Enterprise” and the whole turnover of the Israeli subsidiary. The turnover attributed to the “Benefited Enterprise” is calculated, by taking the increase resulting from the comparison of the Israeli subsidiary’s turnover with its “base” turnover, which is the average turnover attributed to the last three years before the activation of the “Benefited Enterprise”, or by applying such other basis as is stipulated in the instrument of approval. The Israeli subsidiary elected 2005 as its “Implementation Year” as stipulated in the Law, and notified the Israeli Tax Authorities that it elects 2007, 2009 and 2012 as its “Expansion Years”, as stipulated in the Law. In the event of distribution of a cash dividend from income which was tax exempt as set forth above, the Israeli subsidiary would have to pay the 25% tax in respect of the amount distributed.
	The entitlement to the above benefits is conditional upon the Israeli subsidiary’s fulfilling certain conditions. In the event of failure to comply with these conditions, the entitlement for benefits might be cancelled and the Israeli subsidiary might be required to refund the amount of the benefits, in whole or in part, with the addition of linkage differences to the Israeli CPI and interest. As part of the requirements
	necessary to be granted with this status, the Israeli subsidiary was recognized during 2006, by the Chief Scientist Office as a “Research and Development company”. The Company’s management believes that all conditions are fulfilled and therefore these financial statements were prepared under the assumption that the Israeli subsidiary is entitled to those benefits.
	Preferred Company
	In May 2014, as part of the Company’s reorganization of its internal corporate structure, the Israeli subsidiary made an election under the Investment Law to change its tax status from a “Benefited Enterprise” to a “Preferred Company” to be effective as of January 1, 2014. This election was not subject to an approval by Israeli Tax Authority. The change in the tax status did not have a material effect on the Company’s deferred taxes.
	The Investment Law provides certain benefits for income generated by a “Preferred Company” through its “Preferred Enterprise” (as such terms are defined in the Investment Law). The definition of a Preferred Company includes a company incorporated in Israel that is (i) not wholly owned by a governmental entity; (ii) owns a Preferred Enterprise and (iii) that is controlled and managed from Israel, and subject to certain other conditions set in the law. From 2014 and thereafter a Preferred Company is entitled to a reduced corporate tax rate of 16% with respect to its income derived by its Preferred Enterprise, unless the Preferred Enterprise is located in a specified development zone, in which case the rate will be 9%. The Company’s Israeli subsidiary location is entitled to the reduced tax rate of 9%.
	During July 2014, the Company finalized the reorganization of its internal corporate structure. The Company took the necessary steps, including shareholder approval, so that since July 2014, the Company is a resident of Israel (and not The Netherlands) for tax purposes.
	In addition, as part of the reorganization, the Company’s Cypriot subsidiary, which owned all of the Company intellectual property, has transferred all of its intellectual property to the Israeli subsidiary in July 2014.
	On July 20, 2014, the Company obtained a tax ruling from the Israel Tax Authorities providing that, among other matters, the reorganization did not trigger any tax in Israel and did not violate any of the Israeli tax covenants to which the Israeli subsidiary and its shareholder are bound pursuant to a 2001 tax ruling.
	b. Tax assessments
	The Israeli subsidiary has final tax assessments through 2010. Mobileye N.V. has final tax assessments through 2012, and the Cypriot subsidiary has final tax assessments through 2008. All other Company’s subsidiaries have not been assessed since incorporation.
	c. Carryforward tax losses
	During the year ended December 31, 2013, the Company released its valuation allowance on deferred tax assets of the Cypriot subsidiary, as it was no longer in a three-year cumulative loss position and management believed that it is more likely than not that the deferred tax asset will be realized within the foreseeable future. During the year ended December 31, 2014, the Company fully utilized all of the carryforward tax losses of $23,779 related to the Cypriot subsidiary.

	d. Profit (loss) before taxes on income included in the statements of operations
	Profit (loss) before taxes on income is comprised as follows:
			Year ended December 31,
			2014				2013				2012
			U.S. dollars in thousands
	Domestic* (Netherlands)				-222				-109				50
	Domestic* (Israel)				-5,492				—				—
	Foreign*				-12,105				17,755				231
					-17,819				17,646				281


	*
	As mentioned above, since July 2014, the Company is a resident of Israel and not The Netherlands for tax purposes. Therefore, prior to July 2014 “domestic” represented taxing under Dutch tax authorities and as of July 2014 “domestic” represents taxing under the Israeli tax authorities. Thus, in the periods prior to July 2014 taxing under the Israeli tax authorities is included in the table above as foreign profit (loss) before taxes on income.

	e. Benefit (taxes) on income included in the statement of operations
	Benefit (taxes) on income for the years ended December 31, 2014, 2013 and 2012 was composed of the following:
			Year ended December 31,
			2014				2013				2012
			U.S. dollars in thousands
	Current taxes:
	Domestic* (Netherlands)				—				—				—
	Domestic* (Israel)				-4,452				—				—
	Foreign*				-5,589				-713				-327
					-10,041				-713				-327
	Deferred taxes:
	Domestic* (Netherlands)				—				—				—
	Domestic* (Israel)				611	—				—
	Foreign*				-2,835				2,987				-7
					-2,224				2,987				-7
					-12,265				2,274				-334


	* See comment at section 9(d) above.



	f. Taxes on income reconciliation
	A reconciliation of the theoretical tax expense assuming all income is taxed at the statutory rate to taxes on income as reported in the statements of operations:
			Year ended December 31,
		2014				2013				2012
		U.S. dollars in thousands
Income (loss) before taxes on income as reported in the statements of operations				-17,819				17,646				281
Statutory tax rate in the Netherlands for years ended December 31, 2013 and 2012 and weighted average income tax rate for the year ended December 31, 2014*				26.40%				25%				20%
Theoretical tax benefit (taxes on income)				4,704				-4,412				-56
Increase (decrease) in taxes on income resulting from:
Tax adjustment for foreign subsidiaries subject to a different tax rate				-3,605				1,292				-212
Usage of carry forward tax losses in the Cypriot subsidiary				—				3,276				—
Reversal of valuation allowance in the Cypriot subsidiary				—				2,574				—
Non-deductible expenses and other permanent differences				-7,973				-34				-25
Increase in uncertain tax position, net				-5,151				-500				-7
Other				-240				78				-34
Tax benefit (taxes) on income as reported in the statements of operations				-12,265				2,274				-334


*
The theoretical tax benefit (taxes on income) for the year ended December 31, 2014 computed on pre-tax income or loss at the weighted average tax rate has been calculated as the sum of the pre-tax income in the Netherlands and Israel multiplied by that jurisdiction’s applicable statutory tax rate. The statutory tax rates by jurisdiction were 26.5% for Israel and 25% for the Netherlands.

g. Uncertain tax positions
The following is a roll-forward of the Company’s unrecognized tax positions for the years ended December 31, 2014, 2013 and 2012:
		U.S. dollars
		in thousands
Balance at January 1, 2012				895
Increase in unrecognized tax positions as a result of tax positions taken during the				186
current year				186
Decrease in unrecognized tax positions as a result of statute of limitation expirations				-179
Balance at December 31, 2012				902
Increase in unrecognized tax positions as a result of tax positions taken during the				798
current year				798
Decrease in unrecognized tax positions as a result of statute of limitation expirations				-298
Balance at December 31, 2013				1,402
Increase in unrecognized tax positions as a result of tax positions taken during the				5,355
current year				5,355
Decrease in unrecognized tax positions as a result of statute of limitation expirations				-201
Balance at December 31, 2014				6,556

Uncertain tax positions included accrued potential penalties and interest of $73 thousand, $19 thousand and $20 thousand at December 31, 2014, 2013 and 2012, respectively.
All of the above unrecognized tax benefits would affect the effective tax rate if recognized. There are no material anticipated changes in the uncertain tax positions in the next twelve months.
h. Deferred income taxes
Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company’s deferred tax assets and liabilities are as follows:
		December 31,
		2014				2013
		U.S. dollars in thousands
Deferred tax assets
Net operating losses carryforward				100				2,972
Stock-based compensation				390				—
Provisions for employee benefits				115				53
Deferred tax assets – short-term – other current assets				605				3,025
Liability in respect of employee rights upon retirement, net				116				70
Stock-based compensation				136				—
Deferred tax assets, before valuation allowance – Long-term				252				70
Less – valuation allowance				—				—
Deferred tax assets – Long-term				252				70

Realization of this deferred tax balance is conditional upon earning, in the coming years, taxable income. The amount of the deferred tax asset, however, could be reduced in the near term if estimates of future taxable income are reduced.

SUPPLEMENTARY_STATEMENTS_OF_OP

SUPPLEMENTARY STATEMENTS OF OPERATIONS INFORMATION	12 Months Ended
SUPPLEMENTARY STATEMENTS OF OPERATIONS INFORMATION	Dec. 31, 2014
Supplementary Statement Of Operation Information [Abstract]
SUPPLEMENTARY STATEMENTS OF OPERATIONS INFORMATION	NOTE 10 SUPPLEMENTARY STATEMENTS OF OPERATIONS INFORMATION
		Year ended December 31,
		2014		2013		2012
		U.S. dollars in thousands
	a.
	Financial income (expenses), net

	Foreign currency gains (losses), net		-3,104		1,972		688
	Bank charges		-199		-117		-113
	Loss from sales of marketable securities		-1,139		-466		-173
			-4,442		1,389		402

	b.
	The Israeli subsidiary receives grants from the Israeli Ministry of Industry, Trade and Labor, as part of an employment encouragement plan it takes part in. The grants are granted in respect of the Israeli subsidiary hiring new employees and subject to the conditions stipulated in the plan above mentioned. The Israeli subsidiary records these grants as a reduction of salary expenses. Total grants recorded during the years ended December 31, 2013 and 2012 were approximately $149 thousand and $94 thousand, respectively. No grants were recorded during the year ended December 31, 2014.

SEGMENT_INFORMATION

SEGMENT INFORMATION	12 Months Ended
SEGMENT INFORMATION	Dec. 31, 2014
Segment Reporting [Abstract]
SEGMENT INFORMATION	NOTE 11 SEGMENT INFORMATION
	The Company operates under two operating segments: (i) Original Equipment Manufacturing (“OEM”) and (ii) After Market (“AM”).
	The Company’s chief operating decision-maker (CEO of the Company) evaluates performance, makes operating decisions and allocates resources based on the financial data of these operating segments. Segment performance reported excludes stock-based compensation.

	The measure of assets has not been disclosed for each segment as it is not regularly reviewed by the CODM.


	The following is segment results for the years ended December 31, 2014, 2013 and 2012:
		Year ended December 31, 2014
		OEM		AM		Amounts not		Consolidated
						allocated to
						segments
		U.S. dollars in thousands
	Revenues		121,799		21,838				143,637
	Cost of revenues		30,293		6,720		27		37,040
	Gross profit		91,506		15,118				106,597
	Research and development, net		28,995		1,805		6,130		36,930
	Sales and Marketing		560		7,151		5,201		12,912
	General and administrative		5,038		904		65,495		71,437
	Segment performance		56,913		5,258				-14,682
	Interest income								1,305
	Financial expenses, net								-4,442
	Loss before taxes on income								-17,819

		Year ended December 31, 2013
		OEM		AM		Amounts not		Consolidated
						allocated to
						segments
		U.S. dollars in thousands
	Revenues		63,290		17,955				81,245
	Cost of revenues		15,907		5,207		16		21,130
	Gross profit		47,383		12,748				60,115
	Research and development, net		18,362		1,627		2,320		22,309
	Sales and Marketing		337		6,133		5,861		12,331
	General and administrative		4,767		576		4,934		10,277
	Segment performance		23,917		4,412				15,198
	Interest income								1,059
	Financial income, net								1,389
	Profit before taxes on income								17,646


		Year ended December 31, 2012
		OEM		AM		Amounts not		Consolidated
						allocated to
						segments
		U.S. dollars in thousands
	Revenues		27,818		12,467				40,285
	Cost of revenues		8,135		4,052		32		12,219
	Gross profit		19,683		8,415				28,066
	Research and development, net		13,100		1,642		1,124		15,866
	Sales and marketing		438		5,431		565		6,434
	General and administrative		6,750		534		134		7,418
	Segment performance		-605		808				-1,652
	Interest income								1,531
	Financial income, net								402
	Profit before taxes on income								281

ENTITYWIDE_DISCLOSURE

ENTITY-WIDE DISCLOSURE	12 Months Ended
ENTITY-WIDE DISCLOSURE	Dec. 31, 2014
Risks and Uncertainties [Abstract]
ENTITY-WIDE DISCLOSURE	NOTE 12 ENTITY-WIDE DISCLOSURE
	a. Total revenues based on the country that the product is shipped to were as follows:
		As of and for the year ended December 31,
		2014		2013		2012
		U.S. dollars in thousands
	USA		77,680		52,679		24,353
	Japan		2,476		9,642		4,102
	Sweden		16,356		8,743		3,639
	United Kingdom		20,404		724		187
	EUROPE – other		6,617		3,744		2,892
	Israel		12,512		1,995		2,509
	APAC – other		5,999		2,105		1,143
	South America		1,267		1,496		1,370
	Africa		326		117		90
			143,637		81,245		40,285



	b. Major Customers
	Revenues from major customers each of whom amount to 10% or more of total revenues reported in the financial statements (all related to OEM segment):
		Year ended December 31,
		2014		2013		2012
		U.S. dollars in thousands
	Revenues from major customers		103,713		56,941		24,495
	Percent of total revenues
	Customer A		33%		18%		*
	Customer B		23%		34%		29%
	Customer C		11%		11%		*
	Customer D		*		*		11%

	*
	Less than 10%.

	The balance due from Customer A, the Company’s major customer, accounted for 36% and 40% of the accounts receivables at December 31, 2014 and December 31, 2013, respectively.
	c.
	Substantially all of the Company’s property and equipment and long lived assets are located in Israel as of December 31, 2014 and December 31, 2013.

VALUATION_AND_QUALIFYING_ACCOU

VALUATION AND QUALIFYING ACCOUNTS	12 Months Ended
VALUATION AND QUALIFYING ACCOUNTS	Dec. 31, 2014
Valuation and Qualifying Accounts [Abstract]
VALUATION AND QUALIFYING ACCOUNTS	NOTE 13 VALUATION AND QUALIFYING ACCOUNTS
		Warranty		Allowance for		Valuation allowance
		provision		doubtful accounts		for deferred
						tax assets
		U.S. dollars in thousands
	Balance, as of December 31, 2011		243		25		9,936
	Additions		49		—		94
	Deductions		-33		—		-4,180
	Balance, as of December 31, 2012		259		25		5,850
	Additions		136		25		—
	Deductions		-88		—		-5,850
	Balance, as of December 31, 2013		307		50		—
	Additions		261		—		—
	Deductions		-98		—		—
	Balance, as of December 31, 2014		470		50		—

SIGNIFICANT_ACCOUNTING_POLICIE1

SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Use of estimates	a. Use of estimates
	The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclose contingent liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the years reported. Actual results could differ from those estimates. On an on-going basis, management evaluates its estimates, judgments and assumptions. The most significant estimates and assumptions relate to write down of inventory, employee compensation in connection with equity awards, realizability of deferred tax assets, provision for uncertain tax positions and contingencies.
Functional currency	b. Functional currency

	The currency of the primary economic environment in which the operations of the Company and its subsidiaries are conducted is the United States dollar (the “Dollar”).

	Virtually most product revenues of the Company and its subsidiaries are derived in Dollars. Most purchases of materials and components are made in Dollars. Thus, the functional currency of each of the Company and its subsidiaries is the Dollar.
	Monetary accounts maintained in currencies other than the Dollar are re-measured using the official exchange rate at the balance sheet date. Operational accounts and non-monetary balance sheet accounts are measured and recorded at the rate in effect at the date of the transaction or average rates. The effects of foreign currency re-measurements are recorded in the consolidated statements of operations as “financial income (expenses)”.
Principles of consolidation	c. Principles of consolidation
	The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. Intercompany balances and transactions, including profits from intercompany sales not yet realized outside the Company, have been eliminated upon consolidation.
Cash and cash equivalents	d. Cash and cash equivalents
	All highly liquid investments, which include short-term bank deposits, that are not restricted as to withdrawal or use and the period to maturity of which does not exceed three months at the time of investment, are considered to be cash equivalents.
Short-term and restricted bank deposits	e. Short-term and restricted bank deposits
	Short-term and restricted bank deposits are deposits with maturities of more than three months but less than one year. The short-term and restricted bank deposits include approximately $2.2 million and $2.5 million as of December 31, 2014 and December 31, 2013, respectively, as collateral for bank guarantees. In addition, a total of $77 thousand and $78 thousand are restricted as collateral for the Company’s credit cards as of December 31, 2014 and December 31, 2013, respectively.
Marketable securities	f. Marketable securities
	The Company classifies its investments in marketable securities as available-for-sale. Accordingly, these securities are measured at fair value with unrealized gains and losses reported in accumulated other comprehensive income (loss) (“OCI”). Realized gains and losses on sales of investments, and a decline in value that is considered as other than temporary, are included in the consolidated statements of operations as “financial income (expenses), net”. Interest and amortization and accretion of premiums and discounts on debt securities are recorded as interest income.
	The Company classifies marketable securities as available-for-sale as either current or non-current based on maturities and management’s reasonable expectation with regard to those securities.
	An other-than-temporary impairment has occurred if the Company does not expect to recover the amortized cost basis of the debt security. If the Company does not intend to sell the impaired debt security, and it is not more likely than not it will be required to sell the debt security before the recovery of its amortized cost basis, the amount of the other-than-temporary impairment recognized is limited to the portion attributed to the credit loss. The remaining portion of the other-than-temporary impairment related to other factors is recognized in other comprehensive income (loss).
Risk factors	h. Risk factors
	Concentration of credit risk

	Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash equivalents, short-term deposits and marketable securities.

	The Company’s cash equivalents, short-term deposits and marketable securities are mainly invested with major Israeli, Swiss and U.S. banks. Management believes that the financial institutions holding the Company’s investments are financially sound, and accordingly, minimal credit risk exists with respect to these investments. See also notes 2j and 12b for the Company’s major customers.

	Dependence on a single supplier
	The Company purchases all its chips from a single supplier. Any problems that occur and persist in connection with the manufacture, delivery, quality or cost of the assembly and testing of inventory could have a material adverse effect on the Company’s business and financial condition. The agreement expires on December 31, 2022.
Fair value measurement	i. Fair value measurement
	The Company measures fair value and discloses fair value measurements for financial and non-financial assets and liabilities. Fair value is based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The accounting standard establishes a fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described below:
	Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for identical assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.
	Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data or active market data for similar but not identical assets or liabilities.
	Level 3: Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.
	In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible and considers credit risk in its assessment of fair value.
Trade accounts receivable, net	j. Trade accounts receivable, net
	The Company’s accounts receivable balances are due from companies primarily in the car manufacture industry. Credit is given based on an evaluation of a customer’s financial condition and generally, collateral is not required. Trade accounts receivable from sales of products are typically due from customers within 30 – 90 days. Trade accounts receivable balances are stated at amounts due from customers net of an allowance for doubtful accounts. Accounts outstanding longer than their original contractual payment terms, are considered past due. The Company determines its allowance by considering a number of factors, including the length of time accounts receivable are past due, the Company’s previous loss history from such customers, customer’s current ability to pay its obligation to the Company. Payments subsequently received on such receivables are credited to the allowance for doubtful accounts. The allowance for doubtful accounts is determined with respect to specific debts that are doubtful of collection. The Company writes-off accounts receivable when they become uncollectible.
Inventories	k. Inventories
	Inventories are stated at the lower of cost or market value. Cost is computed using standard cost, which approximates average cost. The Company analyzes and adjusts excess and obsolete inventories primarily based on future demand forecasts. Although the Company makes every effort to ensure the accuracy of its forecasts of future product demand, any significant unanticipated changes in demand or technological developments would significantly impact the value of the inventory and the reported operating results. If actual market conditions are less favorable than the Company’s assumptions, additional write-downs may be required.

	Inventories are written-down for estimated excess and obsolescence, based on assumptions about future demand and market conditions. Once written-down, a new lower cost basis for that inventory is established.
Property and equipment	l. Property and equipment
	Property and equipment are recorded at cost and depreciated over their estimated useful lives using the straight-line method.
	Annual rates of depreciation are as follows:
		%
	Computers and electronic equipment (mainly 33%)		15 – 33
	Vehicles		15
	Office furniture and equipment		7
	Equipment		33
	Leasehold improvements are amortized by the straight-line method over the shorter of the term of the lease and estimated useful life of the improvements.
Impairment of long-lived assets	m. Impairment of long-lived assets
	Long-lived assets held and used by the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. In the event that the sum of the expected future cash flows (undiscounted and without interest charges) of the long-lived assets is less than the carrying amount of such assets, an impairment charge would be recognized, and the assets would be written down to their estimated fair values.
Research and development, net	n. Research and development, net
	Research and development expenses are expensed as incurred, and consist primarily of personnel, facilities, equipment and supplies for research and development activities.
	Participations in research and development expenses for research and development projects are recognized on the basis of the costs incurred and are deducted from research and development expenses in the statement of operations. The Company does not receive any additional compensation or royalties upon completion of the project. The participation reimbursement received by the Company is not dependent on having future benefit from the project. All intellectual property generated from these arrangements are exclusively owned by the Company.
	Reimbursement payments for research and development projects are recognized on the basis of the costs incurred and are deducted from (netted against) research and development expenses in the statement of operations. Research and development reimbursements of $9,884 thousand, $10,511 thousand and $9,994 thousand were offset against research and development costs in the years ended in December 31, 2014, 2013 and 2012, respectively.
Comprehensive income (loss)	o. Comprehensive income (loss)
	Comprehensive income (loss) consists of net income (loss) and other gains and losses affecting equity that under US GAAP are excluded from the net income (loss). For the Company, such items consist of unrealized gains and losses on available-for-sale securities. Realized gains and losses on available-for-sale securities are included in the consolidated statements of operations as “financial income (expenses) net”.
Revenue recognition	p. Revenue recognition
	The Company’s revenue results from sales of its products sold through its two operating segments, Original Equipment Manufacturing (“OEM”) and After Market (“AM”).
	The Company recognizes revenue related to sales of its products, net of volume discounts, provided that (i) persuasive evidence of an arrangement exists, (ii) delivery has occurred, (iii) the price is fixed or determinable and (iv) collectibility is reasonably assured. Delivery is considered to have occurred when the product is shipped to the customer and title and risk of loss have transferred to the customer. The Company evaluates the creditworthiness of its customers to determine that appropriate credit limits are established prior to the acceptance of an order.
	Revenue of sales of products to resellers and distributors occurs upon delivery of products to the resellers and distributors. The Company does not give distributors any adjustments to cover price adjustments. The Company does not provide rights of return to its customers.
Shipping and handling	q. Shipping and handling
	Shipping and handling costs on sales are classified as a component of cost of revenues. The Company generally does not charge its customers for such expenses.
Share-based compensation	r. Share-based compensation
	Equity awards granted to employees and directors are accounted for using the grant date fair value. The fair value of share-based payment transactions is determined based on the Black-Scholes option pricing model and recognized as an expense over the requisite service period, net of estimated forfeitures. The Company estimates forfeitures based on historical experience and anticipated future conditions.
	The Company elected to recognize compensation cost for awards that have a graded vesting schedule using the accelerated multiple-option approach.
	Equity awards granted to non-employees are re-measured at each reporting period at fair value until they have vested. The fair value of equity awards is charged to the statement of operations over the service period.
Taxes on income	s. Taxes on income
	Deferred taxes are determined utilizing the assets and liabilities method, which is based on the estimated future tax effects of the differences between the financial accounting and tax bases of assets and liabilities under the applicable tax laws. Deferred tax balances are computed using the tax rates expected to be in effect when those differences reverse. A valuation allowance in respect of deferred tax assets is provided if, based upon the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized.

	The Company did not provide for deferred taxes attributable to dividend distribution out of retained tax-exempt earnings from “Benefitted Enterprise” and “Preferred Company” plans since such earnings are intended to be permanently reinvested or can be recovered in a tax-free manner. Management considers such retained earnings to be essentially permanent in duration. The Company may incur additional tax liabilities in the event of intercompany dividend distributions by its subsidiaries. Such additional tax liabilities in respect of foreign subsidiaries has not been provided for in the Financial Statements, as it is the Company’s intention to permanently reinvest the foreign subsidiaries’ earnings. With respect to domestic subsidiaries, the Company records a deferred tax liability unless the reported amount of the investment can be recovered tax-free without significant cost, and the Company expects to ultimately use that means of recovery.

	Results for tax purposes for the Israeli subsidiary are measured and reflected in NIS (see also Note 9). The Company has not provided deferred income taxes on the differences resulting from changes in exchange rate and indexation.

	The Company follows a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon ultimate resolution. The Company’s policy is to include interest and penalties related to unrecognized tax benefits within income tax expense. Such liabilities are classified as long-term, unless the liability is expected to be settled in cash within twelve months from the balance sheet date.

Provision for warranty	t. Provision for warranty
	The Company provides warranties for its products, which vary with respect to each contract and in accordance with the nature of each specific product, for terms of one to three years.
	The Company estimates the costs that may be incurred under its warranty and records a liability in the amount of such costs at the time the product is shipped. The Company periodically assesses the adequacy of its recorded warranty liabilities and adjusts the amounts as necessary.
	Provision for warranty as of December 31, 2014 and 2013, was $470 thousand and $307 thousand, respectively.
Contingencies	u. Contingencies
	Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. Company’s management assesses such contingent liabilities, which inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company that may result in such proceedings, Company’s management evaluates the perceived merits of any legal proceedings as well as the perceived merits of the amount of relief sought or expected to be sought.
	Management applies the guidance in ASC 450-20-25 when assessing losses resulting from contingencies. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability is recorded in the Company’s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would be disclosed. Legal fees are expensed as incurred.
Basic and diluted net profit (loss) per share	v. Basic and diluted net profit (loss) per share

	Basic earnings (losses) per share are presented in conformity with the two-class method required for participating securities for the periods prior to their conversion upon the Company’s IPO in August 2014, when all classes of shares were converted to Ordinary shares.

	Under the two-class method, the earnings per share for each class of shares are calculated assuming 100% of the Company’s earnings are distributed as dividends to each class of shares based on their contractual rights. In addition, since all classes other than Class A Ordinary shares, did not participate in losses, for the years ended December 31, 2014 and 2012 these shares are not included in the computation of basic loss per share.
	Basic earnings (losses) per share are computed by dividing net income or loss applicable to ordinary shareholders by the weighted average number of Class A ordinary shares outstanding for each period prior to the Company’s IPO and by the weighted-average number of ordinary shares for the periods commencing the Company’s IPO.
	Diluted earnings (losses) per share are calculated by dividing net income or loss applicable to ordinary shareholders by the fully-diluted weighted-average number of Class A ordinary shares outstanding during each period prior to the Company’s IPO and by the weighted-average number of ordinary shares for the periods commencing the Company’s IPO.
	For the years ended December 31, 2014 and 2013, all outstanding options and all Ordinary shares (with liquidation preference) and Class B, C, D, E, F1 and F2 shares were excluded from the calculation of the diluted earnings per share, since their effect was anti-dilutive. For the year ended December 31, 2012, all outstanding options and all Ordinary shares (with liquidation preference) and Class B, C, D and E shares were excluded from the calculation of the diluted earnings per share, since their effect was anti-dilutive.
	During the year ended December 31, 2013, as a result of the investment transaction described in note 8g, the Company redeemed 43,456,175 aggregate shares of classes B, C, D, E and Ordinary shares (with liquidation preference), which were subsequently converted to Class F1 and Class F2 shares and sold to new investors. In connection with this redemption, the Company transferred value to the preferred shareholders, which was calculated as the difference between (1) the fair value of consideration transferred and (2) the carrying value of the 43,456,175 shares of classes B, C, D, E and Ordinary shares (with liquidation preferences) surrendered. The difference, in the amount of $230 million, was recorded as a reduction to net income applicable to Class A Ordinary shares used to calculate basic and diluted loss per share.
	Pro forma basic net loss per share for the year ended December 31, 2014, as presented on the face of the statement of operations, was computed to give effect to the conversion of all convertible preferred shares using the as-if converted method into ordinary shares as if the conversion had occurred as of the beginning of the period presented.
Impact of recently issued accounting pronouncements	w. Impact of recently issued accounting pronouncements
	On May 28, 2014, the FASB and IASB issued their converged standard on revenue recognition. The objective of the revenue standard (ASC 606) is to provide a single, comprehensive revenue recognition model for all contracts with customers to improve comparability within industries, across industries, and across capital markets. The revenue standard contains principles that an entity will apply to determine the measurement of revenue and timing of when it is recognized. The underlying principle is that an entity will recognize revenue to depict the transfer of goods or services to customers at an amount that the entity expects to be entitled to in exchange for those goods or services. For public companies, the revenue standard is effective for the first interim period within annual reporting periods beginning after December 15, 2016 (as of January 1, 2017 for the Company) and early adoption is not permitted. The Company is currently evaluating the impact the standard will have on its financial statements.
	In August 2014, the Financial Accounting Standards Board (“FASB”) issued amended guidance related to disclosure of uncertainties about an entity’s ability to continue as a going concern. The new guidance requires management to evaluate whether there is substantial doubt about the entity’s ability to continue as a going concern and, as necessary, to provide related footnote disclosures. The guidance has an effective date of December 31, 2016. The Company believes that the adoption of this new standard will not have a material impact on its consolidated financial statements.
Adoption of new Accounting Standard	x. Adoption of new Accounting Standard
	In July 2013, the FASB issued ASU No. 2013-11 Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists (ASU No. 2013-11). ASU No. 2013-11 amends the guidance within Accounting Standards Codification (ASC) Topic 740, “Income Taxes”, to require entities to present an unrecognized tax benefit, or a portion of an unrecognized tax benefit, in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward. The Company adopted ASU No. 2013-11 on January 1, 2014. There were no material presentation changes resulting from the adoption of ASU No. 2013-11.

SIGNIFICANT_ACCOUNTING_POLICIE2

SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
SIGNIFICANT ACCOUNTING POLICIES (Tables)	Dec. 31, 2014
Accounting Policies [Abstract]
Schedule of annual rate of depreciation
		%
	Computers and electronic equipment (mainly 33%)		15 – 33
	Vehicles		15
	Office furniture and equipment		7
	Equipment		33

SUPPLEMENTARY_CONSOLIDATED_BAL1

SUPPLEMENTARY CONSOLIDATED BALANCE SHEETS INFORMATION (Tables)	12 Months Ended
	Dec. 31, 2014
Supplementary Statement Of Balance Sheet Information [Abstract]
Schedule of other current assets		December 31,
		2014		2013
		U.S. dollars in thousands
	a. Other current assets
	Government institutions		1,026		856
	Prepaid expenses		1,948		1,260
	Deferred taxes		605		3,025
	Other account receivables		5,277		1,263
	Other		964		621
			9,820		7,025
Schedule of property and equipment

	b. Property and equipment, net
	Computers and electronic equipment		13,848		9,323
	Vehicles		617		656
	Office furniture and equipment		665		541
	Leasehold improvements		3,839		2,928
	Equipment		476		356
			19,445		13,804
	Less – accumulated depreciation and amortization		10,658		8,107
			8,787		5,697

Schedule of account payable and accrued expenses		December 31,
		2014		2013
		U.S. dollars in thousands
	c. Account payable and accrued expenses
	Account payable		12,016		7,550
	Accrued expenses		5,854		3,546
			17,870		11,096
Schedule of other current Liabilities

	d. Other current Liabilities
	Institutions		2,215		90
	Deferred income		1,303		1,052
	Advances from customers		1,180		299
	Other		1,041		—
			5,739		1,441

FAIR_VALUE_MEASUREMENT_Tables

FAIR VALUE MEASUREMENT (Tables)	12 Months Ended
FAIR VALUE MEASUREMENT (Tables)	Dec. 31, 2014
Fair Value Disclosures [Abstract]
Schedule of cost aggregate fair value and unrealized holding gains and losses by major security		As of December 31, 2013
		Cost		Aggregate		Unrealized
		Cost		fair value		gains, net
		U.S. dollars in thousands
	Government and corporate debentures		45,518		46,114		596
	Other (equity securities)		588		604		16
			46,106		46,718		612


Schedule of contractual maturities of investments in available for sale debt securities		Fair Value as of
		December 31,
		2014
	Due in 1 year		7,732
	Due in 2 years		8,011
	Due in 3 years		5,726
	Due in 4 years		6,112
	Due in 5 years		3,773
	Due after 5 years		1,541
			32,895

INVENTORIES_Tables

INVENTORIES (Tables)	12 Months Ended
INVENTORIES (Tables)	Dec. 31, 2014
Inventory Disclosure [Abstract]
Schedule of inventories

		December 31,
		December 31,
			2014		2013
			U.S. dollars in thousands
	Raw materials			2,070		2,387
	Work in process			9		282
	Finished goods and spare parts			15,547		8,685
	Total			17,626		11,354

COMMITMENTS_AND_CONTINGENT_LIA1

COMMITMENTS AND CONTINGENT LIABILITIES (Tables)	12 Months Ended
COMMITMENTS AND CONTINGENT LIABILITIES (Tables)	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Schedule of future minimum annual lease commitments
		U.S. dollars
		in thousands
	Years ending December 31:
	2015		2,141
	2016		2,097
	2017		2,082
	2018		2,082
	2019		347
			8,749

Schedule of other future minimum annual lease commitments under operating lease agreements
		U.S. dollars
		in thousands
	Years ending December 31:
	2015		425
	2016		317
	2017		171
			913

EQUITY_Tables

EQUITY (Tables)	12 Months Ended
EQUITY (Tables)	Dec. 31, 2014
Stockholders' Equity Note [Abstract]
Schedule of summary of equity activity			Ordinary				Class A				Class B				Class C				Class D		Class E		Class F1		Class F2		Ordinary
			shares				Ordinary				Ordinary				Ordinary				Ordinary		Ordinary		Ordinary		Ordinary		shares (with
							shares				shares				shares				shares		shares		shares		shares		liquidation
																											preference)
			Number of shares – issued and outstanding
	Balance, as of December 1, 2012								40,190,595				11,913,135				4,818,795			43,469,535		14,047,435		—		—		77,434,845
	Exercise of options								—				—				—			—		—		—		—		111,540
	Balance, as of December 31, 2012								40,190,595				11,913,135				4,818,795			43,469,535		14,047,435		—		—		77,546,385
	Exercise of options								—				—				—			—		—		—		—		6,229,270
	Issuance of F1 shares								—				—				—			—		—		4,297,995		—		—
	Investment transaction (see note 8(g))								-8,119,760				-5,209,615				-1,428,305			-11,304,580		-2,297,735		10,028,655		41,547,280		-23,215,940
	Balance, as of December 31, 2013								32,070,835				6,703,520				3,390,490			32,164,955		11,749,700		14,326,650		41,547,280		60,559,715
	Exercise of options – prior to IPO				—				—				—				—			—		—		—		—		1,463,051
	Conversion upon IPO closing				203,976,196				-32,070,835				-6,703,520				-3,390,490			-32,164,955		-11,749,700		(14,326,650		(41,547,280		-62,022,766
	IPO				8,325,000				—				—				—			—		—		—		—		—
	Exercise of options – commencing				2,252,865				—				—				—			—		—		—		—		—
	IPO				2,252,865				—				—				—			—		—		—		—		—
	Balance, as of December 31, 2014				214,554,061				—				—				—			—		—		—		—		—

Schedule of summarizes information regarding outstanding and exercisable options	The following table summarizes information regarding outstanding and exercisable options under the Company’s plans as of December 31, 2014:
		Exercise price		Outstanding								Exercisable
		(US $)		Number				Weighted average				Number				Weighted average
								remaining								remaining
								contractual life								contractual life
								(in years)								(in years)
		0.096 – 0.376				2,064,619				2.2				1,959,619				2.05
		0.554 – 0.776				558,620				2				558,620				2
		1.13 – 2.991				2,270,460				1.96				2,270,460				1.96
		3.7				7,480,320				4.6				6,305,750				4.68
		6.98 – 7.1				13,783,600				6.07				4,087,525				6.03
		25 – 36.83				625,100				6.58				—				—
						26,782,719				4.94				15,181,974				4.2

Schedule of summarizes options granted to employees, directors and service providers	The following table summarizes the option activity for the year ended December 31, 2014 for options granted to employees, directors and service providers:
			Number				Weighted				Aggregated
							average				intrinsic value(1)
							exercise price
							$				U.S. dollars
							$				in thousands
	Options outstanding at beginning of year				17,494,470				2.97
	Changes during the year:
	Granted(2)				13,455,700				7.82
	Exercised				-3,715,916				2.73
	Forfeited				-451,535				3.43
	Options outstanding at end of year				26,782,719				5.44				940,693
	Options exercisable at year-end				15,181,974				3.79				558,181


	-1
	The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the closing stock price of $40.56 of the Company’s ordinary share on December 31, 2014. This represents the potential pre-tax amount receivable by the option holders had all option holders exercised their options as of such date.

	-2
	On January 13, 2014 the Company granted the Company’s founders, who are also shareholders, 11,500,000 options, exercisable into the same amount of the Company’s Ordinary shares, at an exercise price of $6.98 per share; 3,850,000 options were vested immediately and the remainder vest over two years.

	On September 7, 2014 the Company granted four of its directors 200,000 options, exercisable into the same amount of the Company’s ordinary shares, at an exercise price of $25.0 per share, which are subject to graded vesting. Those options were granted in the money.
	Subsequent to December 31, 2014, the Company granted to its employee additional 50,650 options exercisable into the same amount of the Company’s Ordinary shares, at an average exercise price of $36.53 per share, and 230,505 RSUs.
Schedule of fair value of options granted			Year ended December 31,
			2014			2013	2012
	Risk-free interest rate		0.7% – 2.17%			0.19% – 2.74%	0.88% – 1.33%
	Expected option term		3.82 – 7.27 years			1 – 12.35 years	6.26 – 7.06 years
	Expected price volatility		36% – 55%			42% – 53%	52% – 53%
	Dividend yield		0%			0%	0%
	Weighted average fair value at the date of grant		$7.28			$2.22	$2.05

Schedule of share-based compensation expenses			Year ended December 31,
			2014				2013				2012
			U.S. dollars in thousands
	Cost of revenues				27				16				32
	Research and development, net				6,130				2,320				1,124
	Sales and marketing				5,201				5,861				565
	General and administrative				65,495				4,934				134
	Total stock-based compensation				76,853				13,131				1,855

TAXES_ON_INCOME_Tables

TAXES ON INCOME (Tables)	12 Months Ended
TAXES ON INCOME (Tables)	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Schedule of profit (loss) before taxes on income		Year ended December 31,
		2014		2013		2012
		U.S. dollars in thousands
	Domestic* (Netherlands)		-222		-109		50
	Domestic* (Israel)		-5,492		—		—
	Foreign*		-12,105		17,755		231
			-17,819		17,646		281


	*
	As mentioned above, since July 2014, the Company is a resident of Israel and not The Netherlands for tax purposes. Therefore, prior to July 2014 “domestic” represented taxing under Dutch tax authorities and as of July 2014 “domestic” represents taxing under the Israeli tax authorities. Thus, in the periods prior to July 2014 taxing under the Israeli tax authorities is included in the table above as foreign profit (loss) before taxes on income.
Schedule of benefit (taxes) on income		Year ended December 31,
		2014		2013		2012
		U.S. dollars in thousands
	Current taxes:
	Domestic* (Netherlands)		—		—		—
	Domestic* (Israel)		-4,452		—		—
	Foreign*		-5,589		-713		-327
			-10,041		-713		-327
	Deferred taxes:
	Domestic* (Netherlands)		—		—		—
	Domestic* (Israel)		611		—		—
	Foreign*		-2,835		2,987		-7
			-2,224		2,987		-7
			-12,265		2,274		-334


	*
	See comment at section 9(d) above.
Schedule of taxes on income reconciliation		Year ended December 31,
		2014		2013		2012
		U.S. dollars in thousands
	Income (loss) before taxes on income as reported in the statements of operations		-17,819		17,646		281
	Statutory tax rate in the Netherlands for years ended December 31, 2013 and 2012 and weighted average income tax rate for the year ended December 31, 2014*		26.40%		25%		20%
	Theoretical tax benefit (taxes on income)		4,704		-4,412		-56
	Increase (decrease) in taxes on income resulting from:
	Tax adjustment for foreign subsidiaries subject to a different tax rate		-3,605		1,292		-212
	Usage of carry forward tax losses in the Cypriot subsidiary		—		3,276		—
	Reversal of valuation allowance in the Cypriot subsidiary		—		2,574		—
	Non-deductible expenses and other permanent differences		-7,973		-34		-25
	Increase in uncertain tax position, net		-5,151		-500		-7
	Other		-240		78		-34
	Tax benefit (taxes) on income as reported in the statements of operations		-12,265		2,274		-334


	*
	The theoretical tax benefit (taxes on income) for the year ended December 31, 2014 computed on pre-tax income or loss at the weighted average tax rate has been calculated as the sum of the pre-tax income in the Netherlands and Israel multiplied by that jurisdiction’s applicable statutory tax rate. The statutory tax rates by jurisdiction were 26.5% for Israel and 25% for the Netherlands.
Schedule of uncertain tax positions		U.S. dollars
		in thousands
	Balance at January 1, 2012		895
	Increase in unrecognized tax positions as a result of tax positions taken during the		186
	current year		186
	Decrease in unrecognized tax positions as a result of statute of limitation expirations		-179
	Balance at December 31, 2012		902
	Increase in unrecognized tax positions as a result of tax positions taken during the		798
	current year		798
	Decrease in unrecognized tax positions as a result of statute of limitation expirations		-298
	Balance at December 31, 2013		1,402
	Increase in unrecognized tax positions as a result of tax positions taken during the		5,355
	current year		5,355
	Decrease in unrecognized tax positions as a result of statute of limitation expirations		-201
	Balance at December 31, 2014		6,556
Schedule of significant components of deferred tax assets and liabilities		December 31,
		2014		2013
		U.S. dollars in thousands
	Deferred tax assets
	Net operating losses carryforward		100		2,972
	Stock-based compensation		390		—
	Provisions for employee benefits		115		53
	Deferred tax assets – short-term – other current assets		605		3,025
	Liability in respect of employee rights upon retirement, net		116		70
	Stock-based compensation		136		—
	Deferred tax assets, before valuation allowance – Long-term		252		70
	Less – valuation allowance		—		—
	Deferred tax assets – Long-term		252		70

SUPPLEMENTARY_STATEMENTS_OF_OP1

SUPPLEMENTARY STATEMENTS OF OPERATIONS INFORMATION (Tables)	12 Months Ended
SUPPLEMENTARY STATEMENTS OF OPERATIONS INFORMATION (Tables)	Dec. 31, 2014
Supplementary Statement Of Operation Information [Abstract]
Schedule of finance expenses transaction		Year ended December 31,
		2014		2013		2012
		U.S. dollars in thousands
	a.
	Financial income (expenses), net

	Foreign currency gains (losses), net		-3,104		1,972		688
	Bank charges		-199		-117		-113
	Loss from sales of marketable securities		-1,139		-466		-173
			-4,442		1,389		402

SEGMENT_INFORMATION_Tables

SEGMENT INFORMATION (Tables)	12 Months Ended
SEGMENT INFORMATION (Tables)	Dec. 31, 2014
Segment Reporting [Abstract]
Schedule of segment results		Year ended December 31, 2014
		OEM		AM		Amounts not		Consolidated
						allocated to
						segments
		U.S. dollars in thousands
	Revenues		121,799		21,838				143,637
	Cost of revenues		30,293		6,720		27		37,040
	Gross profit		91,506		15,118				106,597
	Research and development, net		28,995		1,805		6,130		36,930
	Sales and Marketing		560		7,151		5,201		12,912
	General and administrative		5,038		904		65,495		71,437
	Segment performance		56,913		5,258				-14,682
	Interest income								1,305
	Financial expenses, net								-4,442
	Loss before taxes on income								-17,819

		Year ended December 31, 2013
		OEM		AM		Amounts not		Consolidated
						allocated to
						segments
		U.S. dollars in thousands
	Revenues		63,290		17,955				81,245
	Cost of revenues		15,907		5,207		16		21,130
	Gross profit		47,383		12,748				60,115
	Research and development, net		18,362		1,627		2,320		22,309
	Sales and Marketing		337		6,133		5,861		12,331
	General and administrative		4,767		576		4,934		10,277
	Segment performance		23,917		4,412				15,198
	Interest income								1,059
	Financial income, net								1,389
	Profit before taxes on income								17,646


		Year ended December 31, 2012
		OEM		AM		Amounts not		Consolidated
						allocated to
						segments
		U.S. dollars in thousands
	Revenues		27,818		12,467				40,285
	Cost of revenues		8,135		4,052		32		12,219
	Gross profit		19,683		8,415				28,066
	Research and development, net		13,100		1,642		1,124		15,866
	Sales and marketing		438		5,431		565		6,434
	General and administrative		6,750		534		134		7,418
	Segment performance		-605		808				-1,652
	Interest income								1,531
	Financial income, net								402
	Profit before taxes on income								281

ENTITYWIDE_DISCLOSURE_Tables

ENTITY-WIDE DISCLOSURE (Tables)	12 Months Ended
ENTITY-WIDE DISCLOSURE (Tables)	Dec. 31, 2014
Risks and Uncertainties [Abstract]
Schedule of total revenues based on the country and long-lived assets	As of and for the year ended December 31,
		2014		2013		2012
		U.S. dollars in thousands
	USA		77,680		52,679		24,353
	Japan		2,476		9,642		4,102
	Sweden		16,356		8,743		3,639
	United Kingdom		20,404		724		187
	EUROPE – other		6,617		3,744		2,892
	Israel		12,512		1,995		2,509
	APAC – other		5,999		2,105		1,143
	South America		1,267		1,496		1,370
	Africa		326		117		90
			143,637		81,245		40,285



	Year ended December 31,
		2014		2013		2012
		U.S. dollars in thousands
	Revenues from major customers		103,713		56,941		24,495
	Percent of total revenues
	Customer A		33%		18%		*
	Customer B		23%		34%		29%
	Customer C		11%		11%		*
	Customer D		*		*		11%



	* Less than 10%.

VALUATION_AND_QUALIFYING_ACCOU1

VALUATION AND QUALIFYING ACCOUNTS (Tables)	12 Months Ended
VALUATION AND QUALIFYING ACCOUNTS (Tables)	Dec. 31, 2014
Valuation and Qualifying Accounts [Abstract]
Schedule of valuation allowance and qualifying accounts
		Warranty		Allowance for		Valuation allowance
		provision		doubtful accounts		for deferred
						tax assets
		U.S. dollars in thousands
	Balance, as of December 31, 2011		243		25		9,936
	Additions		49		—		94
	Deductions		-33		—		-4,180
	Balance, as of December 31, 2012		259		25		5,850
	Additions		136		25		—
	Deductions		-88		—		-5,850
	Balance, as of December 31, 2013		307		50		—
	Additions		261		—		—
	Deductions		-98		—		—
	Balance, as of December 31, 2014		470		50		—

GENERAL_Detail_Textuals

GENERAL (Detail Textuals) (USD $)	0 Months Ended	12 Months Ended
	Aug. 06, 2014	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
	Aug. 06, 2014	Segment	Dec. 31, 2013	Dec. 31, 2012
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Number of segment		2
Price per share (in dollars per share)	$25
Proceeds from initial public offering	$197,700,000
Offset expense	1,800,000
Proceeds from option exercised	$1,500,000	$10,151,000	$9,746,000	$272,000
Ordinary shares excluding shares with liquidation preference \| IPO
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Initial public offering ordinary shares issued		8,325,000
Exercise of options - prior to IPO		1,463,051

SIGNIFICANT_ACCOUNTING_POLICIE3

SIGNIFICANT ACCOUNTING POLICIES (Details)	Dec. 31, 2014
Computers and electronic equipment \| Minimum
Property, Plant and Equipment [Line Items]
Annual rates of depreciation	15.00%
Computers and electronic equipment \| Maximum
Property, Plant and Equipment [Line Items]
Annual rates of depreciation	33.00%
Vehicles
Property, Plant and Equipment [Line Items]
Annual rates of depreciation	15.00%
Office furniture and equipment
Property, Plant and Equipment [Line Items]
Annual rates of depreciation	7.00%
Equipment
Property, Plant and Equipment [Line Items]
Annual rates of depreciation	33.00%

SIGNIFICANT_ACCOUNTING_POLICIE4

SIGNIFICANT ACCOUNTING POLICIES (Detail Textuals) (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Accounting Policies [Abstract]
Short-term and restricted bank deposits	$2,200	$2,500
Restricted as collateral	77	78
Research and development reimbursements offset	9,884	10,511	9,994
Provision for warranty	470	307
Percentage of earnings distributed used for calculation under the two-class method	100.00%
Number of ordinary shares redeemed		43,456,175
Reduction to net income applicable to Class A Ordinary shares		$230,000

SUPPLEMENTARY_CONSOLIDATED_BAL2

SUPPLEMENTARY CONSOLIDATED BALANCE SHEETS INFORMATION (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Other current assets
Government institutions	$1,026	$856
Prepaid expenses	1,948	1,260
Deferred taxes	605	3,025
Other account receivables	5,277	1,263
Other	964	621
Other current assets, Total	9,820	7,025
Property and equipment, net
Computers and electronic equipment	13,848	9,323
Vehicles	617	656
Office furniture and equipment	665	541
Leasehold improvements	3,839	2,928
Equipment	476	356
Property and equipment, Gross	19,445	13,804
Less - accumulated depreciation and amortization	10,658	8,107
Property and equipment, net	8,787	5,697
Account payable and accrued expenses
Account payable	12,016	7,550
Accrued expenses	5,854	3,546
Account payable and accrued expenses Total	17,870	11,096
Other current Liabilities
Institutions	2,215	90
Deferred income	1,303	1,052
Advances from customers	1,180	299
Other Liabilities, Miscellaneous, Current	1,041
Other current Liabilities	$5,739	$1,441

SUPPLEMENTARY_CONSOLIDATED_BAL3

SUPPLEMENTARY CONSOLIDATED BALANCE SHEETS INFORMATION (Detail Textuals) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Supplementary Statement Of Balance Sheet Information [Abstract]
Depreciation	$2,551	$1,694	$1,245

FAIR_VALUE_MEASUREMENT_Details

FAIR VALUE MEASUREMENT (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2014
Schedule of Available-for-sale Securities [Line Items]
Cost	$46,106
Aggregate fair value	46,718
Unrealized gains, net	612
Government and corporate debentures
Schedule of Available-for-sale Securities [Line Items]
Cost	45,518	33,228
Aggregate fair value	46,114	32,895
Unrealized gains, net	596
Other (equity securities)
Schedule of Available-for-sale Securities [Line Items]
Cost	588
Aggregate fair value	604
Unrealized gains, net	$16

FAIR_VALUE_MEASUREMENT_Details1

FAIR VALUE MEASUREMENT (Details 1) (USD $)	Dec. 31, 2014
In Thousands, unless otherwise specified	Dec. 31, 2014
Fair Value Disclosures [Abstract]
Due in 1 year	$7,732
Due in 2 years	8,011
Due in 3 years	5,726
Due in 4 years	6,112
Due in 5 years	3,773
Due after 5 years	1,541
Marketable securities	$32,895

FAIR_VALUE_MEASUREMENT_Detail_

FAIR VALUE MEASUREMENT (Detail Textuals) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Fair Value Disclosures [Abstract]
Aggregate amortized cost		$46,106
Aggregate fair value		46,718
Recognized other-than-temporary impairment	152
Short term deposits included in cash and cash equivalents	192,456	31,935
Government and corporate debentures
Fair Value Disclosures [Abstract]
Aggregate amortized cost	33,228	45,518
Aggregate fair value	32,895	46,114
Gross unrealized gains	68
Gross unrealized losses	249
Aggregate fair value of investments with unrealized losses	$19,529

INVENTORIES_Details

INVENTORIES (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Inventory Disclosure [Abstract]
Raw materials	$2,070	$2,387
Work in process	9	282
Finished goods and spare parts	15,547	8,685
Total	$17,626	$11,354

INVENTORIES_Detail_Textuals

INVENTORIES (Detail Textuals) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Inventory Disclosure [Abstract]
Inventory written down	$156	$23	$231

EMPLOYEE_BENEFITS_Detail_Textu

EMPLOYEE BENEFITS (Detail Textuals) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Compensation and Retirement Disclosure [Abstract]
Severance pay expenses	$1,990	$1,433	$1,321
Minimum matching contribution to plan (in percent)	3.00%
Contribution to defined contribution retirement plan	$56	$87	$57

COMMITMENTS_AND_CONTINGENT_LIA2

COMMITMENTS AND CONTINGENT LIABILITIES (Details) (USD $)	Dec. 31, 2014
In Thousands, unless otherwise specified	Dec. 31, 2014
Years ending December 31:
2015	$2,141
2016	2,097
2017	2,082
2018	2,082
2019	347
Future minimum annual lease commitments, Total	$8,749

COMMITMENTS_AND_CONTINGENT_LIA3

COMMITMENTS AND CONTINGENT LIABILITIES (Details 1) (USD $)	Dec. 31, 2014
In Thousands, unless otherwise specified	Dec. 31, 2014
Years ending December 31:
2015	$2,141
2016	2,097
2017	2,082
Future minimum annual lease commitments, Total	8,749
Israeli \| Vehicle operating lease agreements
Years ending December 31:
2015	425
2016	317
2017	171
Future minimum annual lease commitments, Total	$913

COMMITMENTS_AND_CONTINGENT_LIA4

COMMITMENTS AND CONTINGENT LIABILITIES (Detail Textuals)

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

In Thousands, unless otherwise specified

Oct. 31, 2012

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2014

Sep. 30, 2013

Dec. 31, 2014

USD ($)

EUR (€)

USD ($)

Maximum

Minimum

Israeli Subsidiary

USD ($)

Company's founders

Sublease to related party

sqft

sqm

Commitments And Contingent Liabilities [Line Items]

Additional lease agreement term

5 years

Secured bank guarantee

$1,599

$1,283

Rent expenses

2,211

1,447

1,060

Area sublease to related party

9,000

850

Monthly rent per square meter

Vehicles lease expenses

661

600

554

Royalty and commissions expenses

1,768

920

554

Percentage of commission

3.00%

1.00%

Compensation received for early termination of consultancy agreement

$340

€ 260

EQUITY_Details

EQUITY (Details)	12 Months Ended
EQUITY (Details)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Total Shares
Stockholders Equity Note [Line Items]
Balance (in shares)	202,513,145	191,985,880	191,874,340
Exercise of options (in shares)	3,715,916	6,229,270	111,540
Issuance of F1 shares		4,297,995
IPO	8,325,000
Balance (in shares)	214,554,061	202,513,145	191,985,880
Total Shares \| Class A Ordinary shares
Stockholders Equity Note [Line Items]
Balance (in shares)	32,070,835	40,190,595	40,190,595
Exercise of options (in shares)
Issuance of F1 shares
Investment transaction		-8,119,760
Exercise of options - prior to IPO
Conversion upon IPO closing	-32,070,835
IPO
Exercise of options - commencing IPO
Balance (in shares)		32,070,835	40,190,595
Total Shares \| Class B Ordinary shares
Stockholders Equity Note [Line Items]
Balance (in shares)	6,703,520	11,913,135	11,913,135
Exercise of options (in shares)
Issuance of F1 shares
Investment transaction		-5,209,615
Exercise of options - prior to IPO
Conversion upon IPO closing	-6,703,520
IPO
Exercise of options - commencing IPO
Balance (in shares)		6,703,520	11,913,135
Total Shares \| Class C Ordinary shares
Stockholders Equity Note [Line Items]
Balance (in shares)	3,390,490	4,818,795	4,818,795
Exercise of options (in shares)
Issuance of F1 shares
Investment transaction		-1,428,305
Exercise of options - prior to IPO
Conversion upon IPO closing	-3,390,490
IPO
Exercise of options - commencing IPO
Balance (in shares)		3,390,490	4,818,795
Total Shares \| Class D Ordinary shares
Stockholders Equity Note [Line Items]
Balance (in shares)	32,164,955	43,469,535	43,469,535
Exercise of options (in shares)
Issuance of F1 shares
Investment transaction		-11,304,580
Exercise of options - prior to IPO
Conversion upon IPO closing	-32,164,955
IPO
Exercise of options - commencing IPO
Balance (in shares)		32,164,955	43,469,535
Total Shares \| Class E Ordinary shares
Stockholders Equity Note [Line Items]
Balance (in shares)	11,749,700	14,047,435	14,047,435
Exercise of options (in shares)
Issuance of F1 shares
Investment transaction		-2,297,735
Exercise of options - prior to IPO
Conversion upon IPO closing	-11,749,700
IPO
Exercise of options - commencing IPO
Balance (in shares)		11,749,700	14,047,435
Total Shares \| Class F1 Ordinary shares
Stockholders Equity Note [Line Items]
Balance (in shares)	14,326,650
Exercise of options (in shares)
Issuance of F1 shares		4,297,995
Investment transaction		10,028,655
Exercise of options - prior to IPO
Conversion upon IPO closing	-14,326,650
IPO
Exercise of options - commencing IPO
Balance (in shares)		14,326,650
Total Shares \| Class F2 Ordinary shares
Stockholders Equity Note [Line Items]
Balance (in shares)	41,547,280
Exercise of options (in shares)
Issuance of F1 shares
Investment transaction		41,547,280
Exercise of options - prior to IPO
Conversion upon IPO closing	-41,547,280
IPO
Exercise of options - commencing IPO
Balance (in shares)		41,547,280
Ordinary shares excluding shares with liquidation preference
Stockholders Equity Note [Line Items]
Conversion upon IPO closing	203,976,196
IPO	8,325,000
Exercise of options - commencing IPO	2,252,865
Balance (in shares)	214,554,061
Ordinary shares (with liquidation preferences)
Stockholders Equity Note [Line Items]
Balance (in shares)	60,559,715	77,546,385	77,434,845
Exercise of options (in shares)		6,229,270	111,540
Issuance of F1 shares
Investment transaction		-23,215,940
Exercise of options - prior to IPO	1,463,051
Conversion upon IPO closing	-62,022,766
IPO
Exercise of options - commencing IPO
Balance (in shares)		60,559,715	77,546,385

EQUITY_Details_1

EQUITY (Details 1) (Options, USD $)	12 Months Ended
EQUITY (Details 1) (Options, USD $)	Dec. 31, 2014	Dec. 31, 2013
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Outstanding Number	26,782,719	17,494,470
Weighted average remaining contractual life (in years)	4 years 11 months 9 days
Exercisable Number	15,181,974
Weighted average remaining contractual life (in years)	4 years 2 months 12 days
0.096 - 0.376
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Outstanding Number	2,064,619
Weighted average remaining contractual life (in years)	2 years 2 months 12 days
Exercisable Number	1,959,619
Weighted average remaining contractual life (in years)	2 years 18 days
0.096 - 0.376 \| Minimum
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price	0.096
0.096 - 0.376 \| Maximum
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price	0.376
0.554 - 0.776
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Outstanding Number	558,620
Weighted average remaining contractual life (in years)	2 years
Exercisable Number	558,620
Weighted average remaining contractual life (in years)	2 years
0.554 - 0.776 \| Minimum
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price	0.554
0.554 - 0.776 \| Maximum
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price	0.776
1.13 - 2.991
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Outstanding Number	2,270,460
Weighted average remaining contractual life (in years)	1 year 11 months 16 days
Exercisable Number	2,270,460
Weighted average remaining contractual life (in years)	1 year 11 months 16 days
1.13 - 2.991 \| Minimum
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price	1.13
1.13 - 2.991 \| Maximum
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price	2.991
3.7
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price	3.7
Outstanding Number	7,480,320
Weighted average remaining contractual life (in years)	4 years 7 months 6 days
Exercisable Number	6,305,750
Weighted average remaining contractual life (in years)	4 years 8 months 5 days
6.98 - 7.1
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Outstanding Number	13,783,600
Weighted average remaining contractual life (in years)	6 years 26 days
Exercisable Number	4,087,525
Weighted average remaining contractual life (in years)	6 years 11 days
6.98 - 7.1 \| Minimum
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price	6.98
6.98 - 7.1 \| Maximum
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price	7.1
25 - 36.83
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Outstanding Number	625,100
Weighted average remaining contractual life (in years)	6 years 6 months 29 days
25 - 36.83 \| Minimum
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price	25
25 - 36.83 \| Maximum
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price	36.83

EQUITY_Details_2

EQUITY (Details 2) (Options, USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2014
Options
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Number of options outstanding at beginning of year	17,494,470
Changes during the year:
Granted	13,455,700	[1]
Exercised	-3,715,916
Forfeited	-451,535
Number of options outstanding at end of year	26,782,719
Number of options exercisable at year-end	15,181,974
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Weighted average exercise price of options outstanding at beginning of year	$2.97
Changes during the year:
Granted	$7.82	[1]
Exercised	$2.73
Forfeited	$3.43
Weighted average exercise price of options outstanding at end of year	$5.44
Weighted average exercise price exercisable at year-end	$3.79
Aggregated intrinsic value options outstanding at end of year	$940,693	[2]
Aggregated intrinsic value options exercisable at year end	$558,181	[2]

[1]	On January 13, 2014 the Company granted the Company's founders, who are also shareholders, 11,500,000 options, exercisable into the same amount of the Company's Ordinary shares, at an exercise price of $6.98 per share, 3,850,000 options were vested immediately and the remainder vest over two years. On September 7, 2014 the Company granted four of its directors 200,000 options, exercisable into the same amount of the Company's ordinary shares, at an exercise price of $25.0 per share, which are subject to graded vesting. Those options were granted in the money. Subsequent to December 31, 2014, the Company granted to its employee additional 50,650 options exercisable into the same amount of the Company's Ordinary shares, at an average exercise price of $36.53 per share, and 230,505 RSUs.
[2]	The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the closing stock price of $40.56 of the Company's ordinary share on December 31, 2014. This represents the potential pre-tax amount receivable by the option holders had all option holders exercised their options as of such date.

EQUITY_Parentheticals_Details_

EQUITY (Parentheticals) (Details 2) (USD $)	12 Months Ended		0 Months Ended		2 Months Ended
EQUITY (Parentheticals) (Details 2) (USD $)	Dec. 31, 2014		Jan. 13, 2014	Sep. 07, 2014	Mar. 03, 2015	Dec. 31, 2013
Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Closing stock price	$40.56
Number of options granted	13,455,700	[1]
Exercise price of option (in dollars per share)	$7.82	[1]
Options outstanding Number	26,782,719					17,494,470
Weighted average exercise price of outstanding options	$5.44					$2.97
Weighted average remaining contractual life (in years)	4 years 11 months 9 days
Number of options exercisable at year-end	15,181,974
Options \| Officers
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of persons	2		2
Number of options granted			11,500,000
Exercise price of option (in dollars per share)			$6.98
Number of options vested immediately			3,850,000
Vesting period (in years)			2 years
Options \| Directors
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of persons				4
Number of options granted				200,000
Exercise price of option (in dollars per share)				$25
Options \| Service providers
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options outstanding Number	190,000
Weighted average exercise price of outstanding options	$4.17
Weighted average remaining contractual life (in years)	2 years 11 months 12 days
Number of options exercisable at year-end	100,000
Subsequent Event \| Options \| Employee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of options granted					75,650
Exercise price of option (in dollars per share)					$36.49
Subsequent Event \| RSUs \| Employee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of RSUs granted					233,505

[1]	On January 13, 2014 the Company granted the Company's founders, who are also shareholders, 11,500,000 options, exercisable into the same amount of the Company's Ordinary shares, at an exercise price of $6.98 per share, 3,850,000 options were vested immediately and the remainder vest over two years. On September 7, 2014 the Company granted four of its directors 200,000 options, exercisable into the same amount of the Company's ordinary shares, at an exercise price of $25.0 per share, which are subject to graded vesting. Those options were granted in the money. Subsequent to December 31, 2014, the Company granted to its employee additional 50,650 options exercisable into the same amount of the Company's Ordinary shares, at an average exercise price of $36.53 per share, and 230,505 RSUs.

EQUITY_Details_3

EQUITY (Details 3) (USD $)	12 Months Ended
EQUITY (Details 3) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend yield	0.00%	0.00%	0.00%
Weighted average fair value at the date of grant	$7.28	$2.22	$2.05
Options \| Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate	0.70%	0.19%	0.88%
Expected option term (in years)	3 years 9 months 26 days	1 year	6 years 3 months 4 days
Expected price volatility	36.00%	42.00%	52.00%
Options \| Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate	2.17%	2.74%	1.33%
Expected option term (in years)	7 years 3 months 7 days	12 years 4 months 6 days	7 years 22 days
Expected price volatility	55.00%	53.00%	53.00%

EQUITY_Details_4

EQUITY (Details 4) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based compensation expenses	$76,853	$13,131	$1,855
Cost of revenues
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based compensation expenses	27	16	32
Research and development, net
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based compensation expenses	6,130	2,320	1,124
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based compensation expenses	5,201	5,861	565
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based compensation expenses	$65,495	$4,934	$134

EQUITY_Details_Textuals_1

EQUITY (Details Textuals 1)

0 Months Ended

12 Months Ended

1 Months Ended

0 Months Ended

Aug. 06, 2014

Jul. 10, 2014

Dec. 31, 2014

Jun. 28, 2013

Dec. 31, 2013

Aug. 15, 2013

Dec. 31, 2013

Aug. 15, 2013

Dec. 31, 2013

Aug. 15, 2013

Dec. 31, 2013

Aug. 15, 2013

Dec. 31, 2013

Aug. 15, 2013

Aug. 22, 2013

Jun. 28, 2013

Dec. 31, 2013

Aug. 15, 2013

Jun. 28, 2013

Aug. 22, 2013

Jun. 28, 2013

Dec. 31, 2013

Aug. 15, 2013

Jul. 10, 2014

Dec. 31, 2014

Aug. 15, 2013

Jul. 10, 2014

Dec. 31, 2013

Jun. 28, 2013

USD ($)

EUR (€)

Newco

Class A Ordinary shares

Class B Ordinary shares

Class C Ordinary shares

Class D Ordinary shares

Class E Ordinary shares

Class F Ordinary shares

Class F1 Ordinary shares

Class F2 Ordinary shares

Ordinary shares

Ordinary shares (with liquidation preferences)

USD ($)

EUR (€)

USD ($)

EUR (€)

Class A Ordinary shares

Class B Ordinary shares

Class C Ordinary shares

Class D Ordinary shares

Class E Ordinary shares

Class F1 Ordinary shares

Class F2 Ordinary shares

EUR (€)

Newco

Stockholders Equity Note [Line Items]

Ordinary shares, par or stated value per share (in dollars per share)

€ 0.01

Ordinary stock, shares, issued

214,554,061

32,070,835

6,703,520

3,390,490

32,164,955

11,749,700

14,326,650

41,547,280

60,559,715

Ordinary stock, shares, outstanding

214,554,061

32,070,835

6,703,520

3,390,490

32,164,955

11,749,700

14,326,650

41,547,280

60,559,715

Stock split effects

The stock split had the following effects: (i) each outstanding share of any class was increased to five shares of the same class; (ii) each outstanding warrant or option to purchase Ordinary shares was proportionately increased on a five-for-one basis; and (iii) the exercise price of each outstanding warrant or option to purchase Ordinary shares was proportionately decreased on a one-for-five basis.

Stock split ratio

Five-for-one stock split

Number of authorized shares after increase

500,000,000

200,000,000

100,000,000

25,000,000

50,000,000

20,000,000

15,000,000

65,000,000

Ordinary stock, shares authorized

1,012,565,725

100,000,000

25,000,000

50,000,000

20,000,000

80,000,000

15,000,000

65,000,000

200,000,000

Conversion of shares, Description

Convert all classes of shares into one class of Ordinary shares on a 1:1 basis

Ordinary shares voting rights

The holders of Ordinary Shares (with liquidation preference), and Class A, B, C, D, E, F1 and F2 Ordinary shares had identical voting rights. The holders of class D shares have a veto right with respect to certain related party transactions and the right to designate a director of the Company. The holders of F1 shares have the right effectively to designate a director of the Company. The holders of Class D shares and Class F shares have the right to veto further issuances of Class D shares and Class F shares, respectively.

Number of shares agreed to sell and issue

4,297,995

Price per share (in dollars per share)

$25

$6.98

Consideration from shares agreed to sell and issue

$30,000,000

Number of ordinary shares owned

500

Number of shares agrees to sell

10,028,655

41,547,280

Number of shares acquired

51,575,935

Stock purchase price (net of expenses)

$6.61

Conversion of stock shares converted

10,028,655

41,547,280

EQUITY_Details_Textuals_2

EQUITY (Details Textuals 2)	12 Months Ended			0 Months Ended	12 Months Ended		1 Months Ended	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2014	Jan. 13, 2014	Dec. 31, 2014	Dec. 31, 2014	31-May-14	Dec. 31, 2014	Dec. 31, 2014	Dec. 31, 2014
	USD ($)	USD ($)	Options	Options	Options	2003 Plan	2003 Plan	2003 Plan	2014 Plan	2014 Plan
			USD ($)	Officers	Officers	Options	Options	Options	Options	RSUs
				USD ($)	USD ($)	EUR (€)	Employees and Service providers	Employees and Service providers	EUR (€)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of stock option granted							18.00%	11.00%
Number of shares available under 2003 and 2014 Plan	38,619,123
Vesting period (in years)				2 years		4 years 6 months			4 years 6 months	3 years
Options expiration period						7 years			7 years
Exercise price of option (in dollars per share)			$2.73	$6.98		€ 0.01			€ 0.01
Fair value of option pricing model			Black-Scholes option pricing model
Unrecognized compensation expense	$36,900,000
Recognition period of unrecognized compensation expense (in years)	2 years 7 days
Compensation expense upon plan modification		823,000
Ordinary shares vested and exercisable					4,950,000
Number of persons				2	2
Number of shares granted					3,375,000
Compensation expense acceleration cost					$6,600,000

TAXES_ON_INCOME_Details

TAXES ON INCOME (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014		Dec. 31, 2013		Dec. 31, 2012
Income Tax Note [Line Items]
Foreign	($12,105)	[1]	$17,755	[1]	$231	[1]
Profit (loss) before taxes on income	-17,819		17,646		281
NETHERLANDS
Income Tax Note [Line Items]
Domestic	-222	[1]	-109	[1]	50	[1]
ISRAEL
Income Tax Note [Line Items]
Domestic	($5,492)	[1]		[1]		[1]

[1]	As mentioned above, since July 2014, the Company is a resident of Israel and not The Netherlands for tax purposes. Therefore, prior to July 2014 "domestic" represented taxing under Dutch tax authorities and as of July 2014 "domestic" represents taxing under the Israeli tax authorities. Thus, in the periods prior to July 2014 taxing under the Israeli tax authorities is included in the table above as foreign profit (loss) before taxes on income.

TAXES_ON_INCOME_Details_1

TAXES ON INCOME (Details 1) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014		Dec. 31, 2013		Dec. 31, 2012
Current taxes:
Foreign	($5,589)	[1]	($713)	[1]	($327)	[1]
Current income tax expense (benefit)	-10,041		-713		-327
Deferred taxes:
Foreign	-2,835	[1]	2,987	[1]	-7	[1]
Deferred income tax expense (benefit)	-2,224		2,987		-7
Benefit (taxes) on income	-12,265		2,274		-334
NETHERLANDS
Current taxes:
Domestic		[1]		[1]		[1]
Deferred taxes:
Domestic		[1]		[1]		[1]
ISRAEL
Current taxes:
Domestic	-4,452	[1]		[1]		[1]
Deferred taxes:
Domestic	$611	[1]		[1]		[1]

[1]	As mentioned above, since July 2014, the Company is a resident of Israel and not The Netherlands for tax purposes. Therefore, prior to July 2014 "domestic" represented taxing under Dutch tax authorities and as of July 2014 "domestic" represents taxing under the Israeli tax authorities. Thus, in the periods prior to July 2014 taxing under the Israeli tax authorities is included in the table above as foreign profit (loss) before taxes on income.

TAXES_ON_INCOME_Details_2

TAXES ON INCOME (Details 2) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014		Dec. 31, 2013	Dec. 31, 2012
Income Tax Disclosure [Abstract]
Income (loss) before taxes on income as reported in the statements of operations	($17,819)		$17,646	$281
Statutory tax rate in the Netherlands for years ended December 31, 2013 and 2012 and weighted average income tax rate for the year ended December 31, 2014	26.40%	[1]	25.00%	20.00%
Theoretical tax benefit (taxes on income)	4,704		-4,412	-56
Increase (decrease) in taxes on income resulting from:
Tax adjustment for foreign subsidiaries subject to a different tax rate	-3,605		1,292	-212
Usage of carry forward tax losses in the Cypriot subsidiary			3,276
Reversal of valuation allowance in the Cypriot subsidiary			2,574
Non-deductible expenses and other permanent differences	-7,973		-34	-25
Increase in uncertain tax position, net	-5,151		-500	-7
Other	-240		78	-34
Tax benefit (taxes) on income as reported in the statements of operations	($12,265)		$2,274	($334)

[1]	The theoretical tax benefit (taxes on income) for the year ended December 31, 2014 computed on pre-tax income or loss at the weighted average tax rate has been calculated as the sum of the pre-tax income in the Netherlands and Israel multiplied by that jurisdiction's applicable statutory tax rate. The statutory tax rates by jurisdiction were 26.5% for Israel and 25% for the Netherlands.

TAXES_ON_INCOME_Parentheticals

TAXES ON INCOME (Parentheticals) (Details 2)	12 Months Ended
TAXES ON INCOME (Parentheticals) (Details 2)	Dec. 31, 2014		Dec. 31, 2013	Dec. 31, 2012
Income Tax Note [Line Items]
Statutory tax rates by jurisdiction	26.40%	[1]	25.00%	20.00%
NETHERLANDS
Income Tax Note [Line Items]
Statutory tax rates by jurisdiction	25.00%
ISRAEL
Income Tax Note [Line Items]
Statutory tax rates by jurisdiction	26.50%

[1]	The theoretical tax benefit (taxes on income) for the year ended December 31, 2014 computed on pre-tax income or loss at the weighted average tax rate has been calculated as the sum of the pre-tax income in the Netherlands and Israel multiplied by that jurisdiction's applicable statutory tax rate. The statutory tax rates by jurisdiction were 26.5% for Israel and 25% for the Netherlands.

TAXES_ON_INCOME_Details_3

TAXES ON INCOME (Details 3) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Unrecognized tax positions [Roll Forward]
Balance at beginning period	$1,402	$902	$895
Increase in unrecognized tax positions as a result of tax positions taken during the current year	5,355	798	186
Decrease in unrecognized tax positions as a result of statute of limitation expirations	-201	-298	-179
Balance at ending period	$6,556	$1,402	$902

TAXES_ON_INCOME_Details_4

TAXES ON INCOME (Details 4) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Deferred tax assets
Net operating losses carryforward	$100	$2,972
Stock-based compensation	390
Provisions for employee benefits	115	53
Deferred tax assets - short-term - other current assets	605	3,025
Liability in respect of employee rights upon retirement, net	116	70
Stock-based compensation	136
Deferred tax assets, before valuation allowance - Long-term	252	70
Less - valuation allowance
Deferred tax assets - Long-term	$252	$70

TAXES_ON_INCOME_Detail_Textual

TAXES ON INCOME (Detail Textuals) (USD $)	12 Months Ended
TAXES ON INCOME (Detail Textuals) (USD $)	Dec. 31, 2014	Apr. 30, 2014	Dec. 31, 2013	Dec. 31, 2012
Income Tax Note [Line Items]
Tax-exempt profits earned from Benefited Enterprises	$7,000,000
Unrecognized tax benefits, income tax penalties and interest accrued	73,000		19,000	20,000
Cypriot Subsidiary
Income Tax Note [Line Items]
Corporate tax rate	12.50%
Defence tax rate		30.00%
Carryforward tax losses utilized during 2014	$23,779
Israeli Subsidiary
Income Tax Note [Line Items]
Percentage of tax to be paid in respect of distribution of a cash dividend	25.00%
Reduced corporate tax rate	9.00%
Preferred Enterprise
Income Tax Note [Line Items]
Reduced corporate tax rate	16.00%
Tax rate percentage on location of specified development zone	9.00%
ISRAEL
Income Tax Note [Line Items]
Corporate tax rate	26.50%		25.00%	25.00%

SUPPLEMENTARY_STATEMENTS_OF_OP2

SUPPLEMENTARY STATEMENTS OF OPERATIONS INFORMATION (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Financial income (expenses), net
Foreign currency gains (losses), net	($3,104)	$1,972	$688
Bank charges	-199	-117	-113
Loss from sales of marketable securities	-1,139	-466	-173
Financial income (expenses), net, Total	($4,442)	$1,389	$402

SUPPLEMENTARY_STATEMENTS_OF_OP3

SUPPLEMENTARY STATEMENTS OF OPERATIONS INFORMATION (Detail Textuals) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Supplementary Statement Of Operation Information [Abstract]
Grant received by subsidiary entity	$149	$94

SEGMENT_INFORMATION_Details

SEGMENT INFORMATION (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Segment Reporting Information [Line Items]
Revenues	$143,637	$81,245	$40,285
Cost of revenues	37,040	21,130	12,219
Gross profit	106,597	60,115	28,066
Research and development, net	36,930	22,309	15,866
Sales and Marketing	12,912	12,331	6,434
General and administrative	71,437	10,277	7,418
Interest income	1,305	1,059	1,531
Financial income (expense), net	4,442	-1,389	-402
Profit (loss) before taxes on income	-17,819	17,646	281
Operating Segments
Segment Reporting Information [Line Items]
Revenues	143,637	81,245	40,285
Cost of revenues	37,040	21,130	12,219
Gross profit	106,597	60,115	28,066
Research and development, net	36,930	22,309	15,866
Sales and Marketing	12,912	12,331	6,434
General and administrative	71,437	10,277	7,418
Segment performance	-14,682	15,198	-1,652
Interest income	1,305	1,059	1,531
Financial income (expense), net	-4,442	1,389	402
Profit (loss) before taxes on income	-17,819	17,646	281
Operating Segments \| OEM
Segment Reporting Information [Line Items]
Revenues	121,799	63,290	27,818
Cost of revenues	30,293	15,907	8,135
Gross profit	91,506	47,383	19,683
Research and development, net	28,995	18,362	13,100
Sales and Marketing	560	337	438
General and administrative	5,038	4,767	6,750
Segment performance	56,913	23,917	-605
Operating Segments \| AM
Segment Reporting Information [Line Items]
Revenues	21,838	17,955	12,467
Cost of revenues	6,720	5,207	4,052
Gross profit	15,118	12,748	8,415
Research and development, net	1,805	1,627	1,642
Sales and Marketing	7,151	6,133	5,431
General and administrative	904	576	534
Segment performance	5,258	4,412	808
Amounts not allocated to segments
Segment Reporting Information [Line Items]
Cost of revenues	27	16	32
Research and development, net	6,130	2,320	1,124
Sales and Marketing	5,201	5,861	565
General and administrative	$65,495	$4,934	$134

SEGMENT_INFORMATION_Detail_Tex

SEGMENT INFORMATION (Detail Textuals)	12 Months Ended
	Dec. 31, 2014
	Segment
Segment Reporting [Abstract]
Number of operating segments	2

ENTITYWIDE_DISCLOSURE_Details

ENTITY-WIDE DISCLOSURE (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Revenues From External Customers [Line Items]
Total revenues	$143,637	$81,245	$40,285
USA
Revenues From External Customers [Line Items]
Total revenues	77,680	52,679	24,353
Japan
Revenues From External Customers [Line Items]
Total revenues	2,476	9,642	4,102
Sweden
Revenues From External Customers [Line Items]
Total revenues	16,356	8,743	3,639
United Kingdom
Revenues From External Customers [Line Items]
Total revenues	20,404	724	187
EUROPE - other
Revenues From External Customers [Line Items]
Total revenues	6,617	3,744	2,892
Israel
Revenues From External Customers [Line Items]
Total revenues	12,512	1,995	2,509
APAC - other
Revenues From External Customers [Line Items]
Total revenues	5,999	2,105	1,143
South America
Revenues From External Customers [Line Items]
Total revenues	1,267	1,496	1,370
Africa
Revenues From External Customers [Line Items]
Total revenues	$326	$117	$90

ENTITYWIDE_DISCLOSURE_Details_

ENTITY-WIDE DISCLOSURE (Details 1) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014		Dec. 31, 2013		Dec. 31, 2012
Revenue, Major Customer [Line Items]
Revenues from major customers	$143,637		$81,245		$40,285
Revenue
Revenue, Major Customer [Line Items]
Revenues from major customers	$103,713		$56,941		$24,495
Revenue \| Customer A
Revenue, Major Customer [Line Items]
Percent of total revenues	33.00%		18.00%			[1]
Revenue \| Customer B
Revenue, Major Customer [Line Items]
Percent of total revenues	23.00%		34.00%		29.00%
Revenue \| Customer C
Revenue, Major Customer [Line Items]
Percent of total revenues	11.00%		11.00%			[1]
Revenue \| Customer D
Revenue, Major Customer [Line Items]
Percent of total revenues		[1]		[1]	11.00%

[1]	Less than 10%.

ENTITYWIDE_DISCLOSURE_Detail_T

ENTITY-WIDE DISCLOSURE (Detail Textuals)	12 Months Ended
ENTITY-WIDE DISCLOSURE (Detail Textuals)	Dec. 31, 2014	Dec. 31, 2013
Revenue, Major Customer [Line Items]
Concentration risk, customer description	10% or more
Accounts receivable \| Customer A
Revenue, Major Customer [Line Items]
Percentage from accounts receivables for year end	36.00%	40.00%

VALUATION_AND_QUALIFYING_ACCOU2

VALUATION AND QUALIFYING ACCOUNTS (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Warranty provision
Movement in Valuation Allowances and Reserves [Roll Forward]
Balance	$307	$259	$243
Addition	261	136	49
Deductions	-98	-88	-33
Balance	470	307	259
Allowance for doubtful accounts
Movement in Valuation Allowances and Reserves [Roll Forward]
Balance	50	25	25
Addition		25
Deductions
Balance	50	50	25
Valuation allowance for deferred tax assets
Movement in Valuation Allowances and Reserves [Roll Forward]
Balance		5,850	9,936
Addition			94
Deductions		-5,850	-4,180
Balance			$5,850